













































































































Integrins	 are	 the	 key	 receptors	 of	 focal	 adhesions	 and	 crucial	 for	 basic	 cellular	
processes	such	as	adhesion	and	migration.	On	a	molecular	level,	integrins	consist	of	two	
subunits,	 a	 and	 b,	 which	 are	 both	 comprised	 of	 an	 N-terminal	 ectodomain,	




expression	patterns.	Based	on	 structural	 studies	of	 the	 last	 two	decades,	 integrins	are	
thought	to	undergo	conformational	changes	upon	ligand	binding,	i.e.	switch	between	an	
acutely	bent,	low	affinity	and	an	open-extended,	ligand-bound	state.	However,	as	only	a	
couple	of	 integrins	out	of	 the	24	existing	 isoforms	have	been	studied	structurally,	 it	 is	
unclear	whether	the	proposed	canonical	activation	mechanism	applies	to	all	isoforms.		
Integrin	a5b1	 is	 the	ubiquitously	expressed	major	 fibronectin	receptor.	Altered	
expression	or	function	of	either	a5b1	or	fibronectin	can	have	detrimental	consequences	
for	 the	 body	 and	 result	 in	 multiple	 diseases,	 such	 as	 neoangiogenesis	 during	 cancer	
formation.	 To	 fully	 understand	 the	 integrin	a5b1-fibronectin	 activation	mechanism	 in	
atomic	 detail,	 physiological	a5b1	was	 purified	 from	human	placenta	 and	 subjected	 to	
cryo-electron	microscopy	analysis.	The	two	structures	of	resting,	low	affinity	as	well	as	
fibronectin	(‘FN’)-bound	integrin	a5b1	were	obtained	at	resolutions	of	4.6	Å	and	3.1	Å,	











Taken	 together,	 the	 presented	 study	 describes	 how	 integrin	a5b1	 activation	 is	







Integrins	 are	 the	major	 receptors	of	 focal	 adhesions,	 and	 thus	 crucial	 for	many	
basic	 cellular	processes	 such	as	 adhesion,	migration	 and	 tissue	homeostasis.	Aberrant	
function	can	have	detrimental	effects	on	the	body	and	 is	 linked	to	several	pathologies.	
Thus,	it	is	crucial	to	understand	how	cells	manage	to	properly	function	during	adhesion	






in	 one	 publication	 and	 a	 recently	 submitted	 manuscript,	 which	 are	 presented	 in	 a	
cumulative	manner.		
In	chapter	1,	an	introduction	into	focal	adhesion	biology	is	presented.	The	chapter	
summarizes	 the	 current	 knowledge	 of	 the	 field	 and	 gives	 an	 overview	 of	 the	 most	
important	 concepts.	 This	 includes	 how	 focal	 adhesions	 are	 generally	 assembled,	what	
their	molecular	architecture	looks	like	and	how	they	function	under	force	exposure.	Next,	





The	 results	 section	 in	 chapter	 3	 comprises	 two	 sub-chapters:	 in	 chapter	 3.1,	 a	
recently	 submitted	 manuscript	 on	 the	 integrin	 a5b1-fibronectin	 interaction,	 titled	
‘Structural	insights	into	the	integrin	α5β1	crosstalk	with	fibronectin	ligand’	is	presented,	























ABS	 	 	 	 Actin	binding	site	
ADMIDAS	 	 	 Adjacent	to	MIDAS	
Arp	 	 	 	 Actin-related	proteins	
CT	 	 	 	 Cytoplasmic	tail	
DD	 	 	 	 Dimerization	domain	
ECM	 	 	 	 Extracellular	matrix	
EGF	 	 	 	 Epidermal	growth	factor-like	
EM	 	 	 	 Electron	microscopy	
FA	 	 	 	 Focal	adhesion	
FAK	 	 	 	 Focal	adhesion	kinase	
FERM	 	 	 	 4.1-ezrin-radixin-moesin	
FIB	 	 	 	 Focused	ion	beam	
FLIM	 	 	 	 Fluorescence	lifetime	imaging	microscopy	
FN	 	 	 	 Fibronectin	
FRAP	 	 	 	 fluorescence	recovery	after	photobleaching	
FRET	 	 	 	 Förster	resonance	energy	tranfer	
IBS	 	 	 	 Integrin	binding	site	
ICAM	 	 	 	 Intercellular	adhesion	molecule	1	
ICAP1	 	 	 	 integrin	cytoplasmic	domain-associated	protein	1	
ILK	 	 	 	 Integrin-linked	kinase	
IMC	 	 	 	 Inner	membrane	clasp	
iPALM		 	 	 Interferometric	photo-activated	localization	microscopy	
IPP	 	 	 	 ILK-PINCH-parvin		
MD	 	 	 	 Molecular	dynamics	
MIDAS		 	 	 Metal	ion-dependent	adhesion	site	
NA	 	 	 	 Nascent	adhesion	
NMR	 	 	 	 Nuclear	magnetic	resonance	
OMC	 	 	 	 Outer	membrane	clasp	
PINCH		 	 	 Particularly	interesting	new	cysteine-histidine-rich	protein	
PIP2	 	 	 	 Phosphatidylinositol	4,5-biphosphate	
PSI	 	 	 	 Plexin-semaphorin-integrin	
	 xvi	
PTB	 	 	 	 Phosphotyrosine	binding	
RIAM	 	 	 	 Rap1-GTP-interacting	adaptor	molecule	
Salipro	 	 	 Saposin-lipoprotein	
SMALP	 	 	 Styrene	maleic-acid	lipid	particles	
SyMBS		 	 	 Synergistic	metal	ion-binding	site	
TGF-b	 	 	 	 Transforming	growth	factor	b	
TM	 	 	 	 Transmembrane	
aI	 	 	 	 Integrin	a	inserted	domain	











and	 to	 their	environment.	So-called	 focal	adhesions	 (FAs)	are	 large	protein	complexes	
located	at	the	plasma	membrane.	They	fulfill	two	major	purposes;	first,	they	are	involved	
in	mechanically	linking	the	cytoskeleton	of	a	cell	to	the	extracellular	matrix	(ECM),	and	
second,	 they	 sense	 their	 environment	 and	 bidirectionally	 transmit	 signals	 across	 the	
plasma	membrane	(Geiger	et	al.,	2001;	Winograd-Katz	et	al.,	2014;	Wozniak	et	al.,	2004).	
FAs	are	specific	types	of	adhesions	that	are	integrin-based,	i.e.	have	the	transmembrane	




or	 by	 intracellular	 proteins	 connecting	 to	 the	 cytoplasmic	 part	 of	 integrin	 (inside-out	
signaling)	 (Hynes,	 2002).	 During	 outside-in	 signaling,	 binding	 to	 the	 ECM	 results	 in	
integrin	 activation.	 Subsequent	 conformational	 changes	 expose	 intracellular	motifs	 to	
which	key	FA	proteins	talin	and	kindlin	bind.	Integrin’s	interaction	with	talin	and	kindlin	






Despite	 the	 plethora	 of	 proteins	 associated	 with	mature	 FAs,	 only	 a	 couple	 of	
proteins,	such	as	kindlin,	talin	and	vinculin,	are	essential	for	initial	FA	assembly,	i.e.	for	
the	 formation	 of	 so-called	 nascent	 adhesions	 (NA)	 (Bachir	 et	 al.,	 2014).	 The	 precise	














types,	 protein	 isoforms,	 the	 high	 number	 of	 proteins	 involved	 as	 well	 as	 assembly	
dynamics.	 Still,	 some	 general	 conclusions	 have	 been	 drawn,	 especially	 by	 employing	
super-resolution	microscopy	techniques	(Case	et	al.,	2015;	Kanchanawong	et	al.,	2010;	
Paszek	 et	 al.,	 2012)	 and	 cryo-electron	 tomography	 (Patla	 et	 al.,	 2010).	 Via	 super-
resolution	 techniques,	 the	 following	 organizational	 properties	 of	 adhesions,	 both	 in	
vertical	(perpendicular	to	plasma	membrane)	as	well	as	lateral	(parallel	to	membrane)	
direction	have	been	found	to	be	conserved:	





(Figure	 1).	 Each	 layer	 contains	 distinct	 sets	 of	 proteins,	 except	 for	 talin,	 the	 major	
connector	between	integrin	and	actin,	which	spans	over	all	three	layers	(Liu	et	al.,	2015).	
Laterally,	 it	 has	 been	 observed	 that	 when	 FAs	 mature,	 they	 elongate	 in	 the	
direction	of	the	actin	retrograde	flow,	and	that	proteins	such	as	talin	and	vinculin	align	in	
the	 same	 direction	 (Choi	 et	 al.,	 2008;	Margadant	 et	 al.,	 2011;	 Zaidel-Bar	 et	 al.,	 2003).	
Furthermore,	it	has	been	shown	that	nanoclusters	form	within	adhesions,	which	consist	
of	 integrin	 islands	 (Spiess	 et	 al.,	 2018).	 This	 organization	 has	 been	 compared	 to	 an	
‘archipelago	architecture’,	where	 integrin	 islands	can	diffuse	 rapidly	 in	and	out	of	FAs	
(Shibata	 et	 al.,	 2012),	while	 the	overall	 architecture	of	 the	FA	 itself	 appears	 relatively	
stable.	This	concept	allows	for	fast	turnover	of	proteins	and	thus	flexible	adjustment	of	



























NAs	 periodically	 fluctuate	 between	 assembly	 and	 disassembly	 until	 they	
eventually	mature	 into	 full	 FAs	which	 are	 larger	 (up	 to	 several	µm)	 and	 longer-lived	
(~20	min).	FAs	might	further	mature	into	even	larger	and	longer-lived	fibrillar	adhesions,	
which	 are	 associated	 with	 fibronectin	 fibrillogenesis	 (Geiger	 and	 Yamada,	 2011).	





Interestingly,	 although	 it	 is	 generally	 accepted	 that	 FAs	 have	 a	 well-organized	
architecture,	the	exact	hierarchical	steps	of	the	assembly	process	are	still	unclear.	A	study	






detachment	 and	 movement.	 The	 exact	 spatiotemporal	 mechanisms	 are	 still	 unclear;	
however,	it	has	been	suggested	that	altered	local	plasma	membrane	composition	as	well	








constantly	 exposed	 to	 mechanical	 forces,	 generated	 by	 both	 constant	 actin	





and	 Kirschner,	 1988).	 The	 molecular	 clutch	 system	 consists	 of	 adaptor	 proteins	 and	
integrins,	which	link	the	force-generating	cytoskeleton	to	the	ECM	(Elosegui-Artola	et	al.,	
2018).	 When	 engaged	 in	 binding	 to	 the	 ECM,	 the	 molecular	 clutch	 transmits	 the	
retrograde	 flow	 of	 actin	 into	 forward	 movement	 of	 a	 cell.	 The	 interplay	 between	 all	
components	 of	 the	 molecular	 clutch	 as	 well	 as	 their	 individual	 behavior	 under	 force	
affects	 cell	 migration	 as	 well	 as	 mechanosensitivity.	 Mechanosensitivity	 (or	 rigidity	
sensing)	 describes	 the	 ability	 of	 a	 cell	 to	 transduce	 force	 into	 biochemical	 signals	 in	
























consist	 of	 a	 large	 extracellular	 domain	 (~800	 amino	 acids),	 followed	 by	 a	 single	
transmembrane	helix	 (~20	amino	acids)	and	a	short	cytoplasmic	 tail	domain	(~13-70	
amino	 acids)	 (Moser	 et	 al.,	 2009b).	 Integrins	 can	 be	 divided	 into	 four	 subclasses,	
depending	on	their	ligand	recognition	profile,	i.e.	by	binding	to	RGD,	collagen,	laminin	or	
leucocyte-specific	receptors	(Figure	2).	
Figure	 2:	 Integrin	 family	 divided	 into	 subclasses	 by	 ligand	
specificity.		
18	 a	 and	 8	 b	 subunits	 form	 24	 different	 integrins.	 These	 can	 be	













can	 also	 be	 regulated	 by	 binding	 of	 intracellular	 proteins	 (inside-out	 signaling).	 By	
changing	 their	 structural	 conformation	 from	 a	 bent-closed	 to	 an	 extended-open	 state	
(Hynes,	2002),	integrins	can	integrate	and	transduce	stimuli	across	the	plasma	membrane	
which	 affects	 downstream	 signaling	 and	 cell	 fate	 (Legate	 et	 al.,	 2009).	 These	
conformational	states	of	 integrins	are	highly	 linked	to	their	 ligand	binding	affinity	and	
will	be	described	in	more	detail	in	the	chapter	below.		
Integrins	are	involved	in	a	variety	of	processes,	ranging	from	tissue	development,	
maintenance	 and	 angiogenesis	 to	 leucocyte	 functions	 such	 as	 leucocyte	 rolling	 and	




collagen,	 via	 their	 extracellular	 domains.	 They	 are	 partially	 promiscuous	 in	 their	
behavior,	since	some	integrins	are	able	to	bind	to	more	than	one	ligand	(Humphries	et	al.,	
2006).	Vice	versa,	some	ligands	can	bind	to	multiple	integrins	as	well	(Humphries	et	al.,	
2006;	 Humphries,	 1990;	 Plow	 et	 al.,	 2000;	 van	 der	 Flier	 and	 Sonnenberg,	 2001).	
Interestingly,	although	integrins	can	share	a	set	of	ligands,	they	are	non-redundant.	This	
was	shown	by	knockout	experiments,	in	which	each	isoform	knockout	in	mice	resulted	in	
severe	 phenotypes,	 ranging	 from	 early	 embryonic	 lethality	 to	 defects	 in	 angiogenesis,	
inflammation	or	leucocyte	function	(Hynes,	2002).	
Inside	 the	cell,	 integrins	 form	the	connection	between	the	cytoskeleton	and	the	
ECM	via	linker	proteins	such	as	talin	and	kindlin	(Hynes,	2002).	Except	for	integrin	b4,	
the	 cytoplasmic	 tails	 of	 all	 b	 subunits	 can	 interact	 with	 talin	 and	 kindlin	 by	 two	
recognition	motifs,	NPxY	and	NxxY	(where	 ‘x’	stands	 for	any	amino	acid)	(Moser	et	al.	
















following	years,	numerous	 structural	 studies	 followed,	 all	 revolving	around	 the	highly	
debated	question:	how	are	conformation	and	activity	of	integrin	linked?		
In	this	part,	an	overview	about	structural	knowledge	will	be	presented,	followed	



















The	b	 subunit’s	 ectodomain	 is	 comprised	of	8	domains:	 the	b	 inserted-like	 (bI)	
domain,	 which	 is	 homologous	 to	 the	 aI	 domain,	 is	 followed	 by	 a	 hybrid,	 a	 plexin-
semaphorin-integrin	(PSI),	four	integrin	epidermal	growth	factor-like	(EGF	1-4)	and	the	
b-tail	domains	(Figure	3	A,	B).	Interestingly,	this	arrangement	of	the	domains	is	seen	in	







Ca2+	 and	 Mg2+	 (Zhang	 and	 Chen,	 2012).	 Structurally,	 3-4	 Ca2+	 ions	 contribute	 to	 the	





Functionally,	 both	 Ca2+	 and	 Mg2+	 ions	 are	 involved	 in	 ligand	 binding	 and	
conformational	changes	(Luo	et	al.,	2007;	Zhang	and	Chen,	2012).	There	are	three	metal	
ion	 binding	 sites	 in	 the	bI	 domain,	 that	 are	 crucial	 for	 ligand	 binding:	 the	metal	 ion-
dependent	adhesion	site	(MIDAS),	the	adjacent	to	MIDAS	(ADMIDAS)	and	the	synergistic	
metal	 ion-binding	 site	 (SyMBS)	 (Zhang	 and	Chen,	 2012)	 (Figure	4).	 The	MIDAS	has	 a	
coordinated	 Mg2+	 ion	 that	 is	 directly	 involved	 in	 binding	 negatively	 charged	 ligand	
residues	(described	in	more	detail	below).	The	MIDAS	contains	the	common	motif	Asp-X-
Ser-X-Ser	(Xiong	et	al.,	2001).	Similarly,	in	aI-containing	integrins,	the	aI	domain	contains	
a	MIDAS	which	 is	 used	 for	 ligand	 recognition	 instead	 of	 the	MIDAS	 located	 in	 the	bI	
domain.	In	the	bI	domain,	two	other	metal	ion	binding	sites	flank	the	MIDAS.	Next	to	the	













C:	Three	 activation	 states	 of	aI-less	 integrins:	 (1.)	 bent,	 (2.)	 extended-closed	 and	 (3.)	 extended-open.	Upon	 ligand	
binding,	displacement	of	the	a7	helix	(black	bar	in	state	2	and	3)	 leads	to	a	swing-out	of	the	hybrid	domain,	which	
results	in	headpiece	opening.	
D:	Three	 activation	 states	 of	aI-containing	 integrins:	 (1.)	 bent,	 (2.)	 extended-closed	 and	 (3.)	 extended-open.	 Upon	













it	 was	 found	 to	 be	 altered	 upon	 injury.	 Increased	Mg2+	 concentrations	were	 found	 in	












Integrins	 bind	 to	 their	 respective	 ligands	 via	 their	 ectodomains.	 In	 integrins	
without	aI	domains,	such	as	RGD-recognizing	integrins,	the	binding	pocket	is	located	in	a	
cleft	between	the	b-propeller	of	the	a	subunit	and	the	bI	domain	of	the	b	subunit.	The	RGD	




coordinates	 Mg2+	 which	 is	 directly	 binding	 to	 negatively	
charged	 ligand	 residues.	 It	 is	 flanked	 by	 SyMBS	 (left,	
coordinating	 amino	 acids	 labelled	 in	 yellow)	 and	 ADMIDAS	
(right,	coordinating	amino	acids	labelled	 in	blue)	which	both	
bind	Ca2+	and	either	positively	or	negatively	regulate	binding	







ion	 of	 the	MIDAS	within	 the	bI	 subunit.	 For	aI-containing	 integrins,	 ligand	 binding	 is	





Both	 a	 and	 b	 subunit	 contain	 a	 single	 transmembrane	 (TM)	 helix.	 These	 TM	
segments	comprise	between	23	and	29	amino	acids	and	have	been,	despite	their	small	




integrin,	 23	 hydrophobic	 residues	 form	 a	 helix	 (I966-K989),	 followed	 by	 four	
hydrophobic	 residues	 which	 are	 still	 embedded	 into	 the	 lipid	 bilayer	 (Ulmer,	 2010)	
















close	 to	 the	 negatively	 charged	 phospholipid	 head	 groups.	 This	 residue,	 termed	
‘snorkeling’	lysine,	has	been	denoted	as	one	of	the	main	components	stabilizing	both	the	
helix	 tilt	 as	 well	 as	 the	 interaction	 between	 the	 two	 segments,	 especially	 for	 aIIbb3	
integrin	(Kim	et	al.,	2011).	However,	in	a	study	testing	the	effect	of	mutations	of	this	lysine	
in	 different	 integrins,	 it	 has	 been	 observed	 that	 the	mechanism	 derived	 from	 platelet	
integrin	aIIbb3	might	not	apply	to	all	integrins	(Lu	et	al.,	2016).	
	
The	 cytoplasmic	 tails	 (CT)	of	 integrins	 are	 relatively	 short,	 ranging	 from	10-70	
amino	acids	in	length,	except	for	the	b4	tail,	which	contains	~1000	amino	acids.	Integrin	
CT	 domains	 were	 reported	 to	 interact	 via	 a	 salt	 bridge	 formed	 by	 R995(aIIb)	 and	
D723(b3),	an	extended	part	of	the	IMC	that	is	outside	of	the	lipid	bilayer	(Hughes	et	al.,	











The	CT	domains	are	mostly	disordered,	but	 contain	 recognition	motifs	 that	 are	
important	 for	 intracellular	 signaling	 pathways.	 Despite	 their	 small	 size,	 integrin	 CT	








et	 al.,	 2002).	 The	 second	 motif,	 the	 membrane-proximal	 NPxY	 motif,	 is	 part	 of	 the	
	 14	
recognition	motif	 for	phosphotyrosine	binding	(PTB)-containing	proteins,	such	as	talin	
and	 dok1	 (Calderwood	 et	 al.,	 2002;	 Yamanashi	 and	 Baltimore,	 1997).	 While	 some	
intracellular	PTB-containing	proteins	bind	to	one	specific	integrin,	some	others	can	bind	
to	 multiple	 integrin	 tails	 (Calderwood	 et	 al.,	 2003).	 Talin	 is	 one	 of	 the	 most	 studied	












regulation	 exists	 (Legate	 and	 Fassler,	 2009).	 Phosphorylation	 mechanisms	 could	 be	





























B:	 The	 structure	 of	 the	 TM	 domains,	 as	 determined	 by	 NMR	 (2k9j),	 is	 shown.	 The	 residues	
involved	 in	TM	stabilization	are	depicted.	OMC=outer	membrane	clasp,	 IMC=inner	membrane	
clasp.		






Studies	 of	 the	 last	 two	 decades,	 employing	 various	 techniques,	 such	 as	 X-ray	
crystallography,	 electron	 microscopy,	 NMR	 as	 well	 as	 light	 microscopy	 approaches	




and	 extended-open	 (Campbell	 and	 Humphries,	 2011;	 Hynes,	 2002;	 Luo	 et	 al.,	 2007)	
(Figure	3	C,	D).	In	the	bent	state,	the	structure	has	a	‘folded’	appearance,	where	the	head	
is	 in	 close	proximity	 to	 the	 legs	 and	 the	 legs	 are	 closely	 contacting	each	other.	 In	 this	























The	 molecular	 mechanism	 underlying	 these	 conformational	 changes	 has	 been	
thoroughly	investigated.	Initially,	a	lot	has	been	learned	from	the	truncated	aI	domains	




































global	 conformations	 (Luo	 et	 al.,	 2007).	 Hybrid	 domain	 swing-out	 leads	 to	 headpiece	




2008b;	 Luo	 et	 al.,	 2004).	 The	 described	 activation	 mechanism	 enables	 the	 step-wise	
transmission	of	the	signal	across	the	whole	molecule,	from	N-	to	C-terminus.		
Inside-out	activation,	i.e.	the	modulation	of	ligand	binding	affinity	by	intracellular	







For	aI-containing	 integrins,	 the	molecular	 activation	mechanism	 follows	a	 very	
similar	process	(Figure	3	D).	However,	the	aI	domain	with	its	own	MIDAS	is	the	domain	









The	 importance	 of	 a	 tight	 control	 on	 ligand	 binding	 affinity	 and	 the	 linked	
conformation	is	best	displayed	by	integrins	found	on	migrating	cells,	such	as	leucocytes	
(e.g.	aXb2)	and	platelets	(aIIbb3).	Platelets	need	to	be	completely	inactive	until	they	are	
needed	 during	 injury.	 Thus,	 platelet	 integrin	aIIbb3	 should	 undergo	 quickly	 a	 severe	
conformational	change	that	renders	it	inactive	(acutely	bent	form)	or	active	(completely	
extended).	Otherwise,	severe	bleeding	disorder	or	thrombosis	could	occur	(Hynes,	2002;	
Kato,	 1997).	 Similarly,	 leucocytes	 might	 not	 be	 able	 to	 function	 properly	 in	 immune	
responses,	if	integrin	function	is	impaired	(Hynes,	2002;	Rosenkranz	and	Mayadas,	1999).	
























The	 concept	 that	 integrin’s	 conformational	 changes	 are	 linked	 to	 its	 affinity,	
escpecially	 that	 active	 integrin	 functions	 in	 its	 extended	 state,	 has	 been	 termed	 the	
‘switchblade	model’	(Luo	et	al.,	2007;	Takagi	et	al.,	2002).	In	some	studies,	it	has	also	been	
proposed	that	 integrin	might	 function	 in	 its	bent	state	only;	a	concept	which	has	been	
summarized	as	the	‘deadbolt	model’	(Adair	et	al.,	2005;	Arnaout	et	al.,	2005;	Xiong	et	al.,	
2009;	Xiong	et	al.,	2003;	Xiong	et	al.,	2002).	However,	 it	has	been	extensively	debated	







extended	 and	 functions	 without	 the	 major	 changes	 between	 bent	 and	 extended	
conformations	(Campbell	et	al.,	2020;	Cormier	et	al.,	2018).	Integrin	avb8	is	thought	to	
‘search’	for	ligands	by	rotation	of	its	headpiece	in	a	‘sunflower-like’	motion	(Campbell	et	





different	parts	on	both	subunits	might	contribute	 in	opposite	ways	 to	maintaining	 the	






Overall,	 all	 of	 these	 different	 observations	 are	 difficult	 to	 explain	 by	 only	 one	
activation	model.	 Since	 several	portions	of	both	 subunits	 could	 contribute	 in	different	
ways	to	the	bending	or	extension	of	integrin,	and	there	are	24	different	combinations,	one	
	 21	












2007;	 Astrof	 et	 al.,	 2006;	 Evans	 and	 Calderwood,	 2007;	 Zhu	 et	 al.,	 2008).	 Pulling	 on	
integrins	might	stabilize	their	extended-open	conformation	and	ligand	binding	affinity.	
This	 feature	marks	 the	 integrin-ligand	 connection	 as	 a	 catch-bond,	 i.e.	 a	 bond	 that	 is	


















Interestingly,	 it	 has	 been	 observed	 that	 all	 bound	 aLb2	 integrins	 align	 in	 the	








force	 transduction	 (Sun	 et	 al.,	 2019;	 Sun	 et	 al.,	 2016a).	 Via	 integrin	 clustering,	 more	
integrin	 molecules	 are	 concentrated	 at	 a	 single	 point	 and	 can	 divide	 the	 growing	
mechanical	 force	 among	 them	 (Moore	 et	 al.,	 2010).	 Furthermore,	 as	 integrins	 are	
continuously	 switching	 between	 conformational	 states,	 the	 probability	 of	 a	 single	
dissociated	integrin	to	reattach	to	the	ECM	is	greatly	increased	if	it	is	still	part	of	a	cluster	
that	is	overall	ECM-bound	and	interacting	with	intracellular	proteins	(Schoen	et	al.,	2013;	
Sun	et	al.,	2016a).	 Interestingly,	 there	 is	also	evidence	 that	different	 types	of	 integrins	
with	diverse	mechanical	features	can	work	together	within	the	same	adhesion;	i.e.	a5b1	
integrins	 can	 form	 stronger	 bonds	 to	 fibronectin,	 while	 avb3	 manages	 intracellular	
protein	recruitment	(Roca-Cusachs	et	al.,	2009).	
Although	 there	 have	 been	 some	 studies	 which	 reported	 homodimerization	

















the	 complete	mechanism,	 studies	 on	 full-length	 are	 required.	 Indeed,	 there	 are	 some	
structural	studies	on	full-length	integrin,	embedded	in	either	nanodiscs	(Choi	et	al.,	2013;	
Dai	et	al.,	2015;	Xu	et	al.,	2016;	Ye	et	al.,	2010),	liposomes	(Ye	et	al.,	2010)	or	solubilized	




In	 general,	 EM	 is	 a	 powerful	 tool	 for	 studying	 membrane	 proteins	 in	 a	 more	








Another	 interesting	 aspect	 of	 integrin	 function	 is	 its	 connection	 to	 post-







How	 much	 integrins	 depend	 on	 N-glycosylation	 has	 been	 demonstrated	 in	 a	
number	of	studies.	When	purified	integrin	a5b1	was	deglycosylated	by	PNGase-F,	loss	of	





linked	 to	 decreased	 cellular	 adhesion	 in	 vitro	 (Akiyama	 et	 al.,	 1989)	 and	 of	a3b1	 to	
enhanced	tumor	development	and	metastasis	(Pochec	et	al.,	2003).	Conversely,	elevated	
levels	of	N-acetylglucosaminyltransferase	V,	a	well-characterized	and	cancer-associated	











polymers	 as	 part	 of	 the	 ECM	 (Schwarzbauer	 and	 Sechler,	 1999).	 Although	 the	 exact	
mechanism	of	polymerization	is	not	completely	understood	so	far,	it	seems	to	occur	upon	
binding	 to	 activated	 integrin	 a5b1	 on	 cell	 surfaces.	 The	 subsequent	 stretching,	 i.e.	
mechanical	 stress	 transmitted	 from	 the	 cytoskeleton,	 leads	 to	 conformational	 changes	
within	FN	resulting	in	exposure	of	sites	which	promote	self-association	(Johansson	et	al.,	
1997;	 Mao	 and	 Schwarzbauer,	 2005;	 Schwarzbauer	 and	 Sechler,	 1999;	 Sechler	 et	 al.,	
1996;	Singh	et	al.,	2010).	A	single	FN	molecule	is	about	~250	kDa	in	size	and	contains	









(Mould	et	al.,	1997).	The	synergy	site	 is	 comprised	of	 the	8	amino	acid	 long	sequence	
DRVPHSRN	 on	 FN9	 (Aota	 et	 al.,	 1991;	 Redick	 et	 al.,	 2000).	 Mutational	 studies	 have	
determined	the	two	arginines	R1374	and	R1379	within	this	sequence	as	key	residues	for	
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a	 stable	 a5b1-fibronectin	 interaction	 (Redick	 et	 al.,	 2000).	 The	 exact	 function	 of	 the	




integrin	 (Main	 et	 al.,	 1992;	 Takagi	 et	 al.,	 2003).	 Kinetic	 analyses	 via	 surface	 plasmon	
resonance	showed	that	mutations	in	the	synergy	site	led	to	a	decrease	in	both	affinity	as	
well	 as	 association	 rate,	 which	 suggests	 that	 the	 synergy	 site	 promotes	 the	 initial	
encounter	between	the	two	molecules	FN	and	a5b1	(Takagi	et	al.,	2003).	Mutational	and	
modelling	studies	have	shown	that	the	interaction	between	R1379	in	the	synergy	site	and	































Mutations	 in	 the	FA	adhesome	correlate	highly	 to	human	genetic	diseases.	 In	a	
study	from	2014,	it	was	shown	that	roughly	60%	of	the	FA-associated	proteins	are	linked	
to	 cardiovascular,	 musculoskeletal,	 hematopoietic,	 dermatological	 or	 developmental	
disorders,	as	well	as	cancerogenesis	(Winograd-Katz	et	al.,	2014).		
Especially	 integrins	 are	 of	 high	 interest	 for	 pharmaceutical	 research	 regarding	
treatment	of	cancer,	inflammation	and	fibrosis,	due	to	their	diverse	roles	in	cell	migration	
and	 adhesion.	 New	 approaches	 are	 developed	 constantly,	 partially	 by	 employing	
structural	 knowledge	 of	 integrins	 for	 design	 of	 antagonists	 and	 agonists	 (Zheng	 and	
Leftheris,	 2020).	 Since	 integrins	 are	 cell	 surface	 receptors,	 clinical	 antibodies	 are	 a	





In	 addition	 to	 its	 role	 in	 general	 processes	 related	 to	 cellular	 adhesion	 and	
migration,	 the	a5b1	receptor	 is	 also	 relevant	 for	angiogenesis	 (Schaffner	et	 al.,	 2013).	
Knockout	of	b1	in	mice	resulted	in	pre-implantation	lethality	of	embryos	(Hynes,	2002)	




diagnostic	 marker	 for	 some	 solid	 tumors	 and	 is	 indicated	 to	 play	 a	 role	 in	 tumor	
neoangiogenesis	(Schaffner	et	al.,	2013).	Integrin	a5b1	has	been	the	subject	of	extensive	
studies	that	connect	it	to	malignant	melanomas	and	liver-specific	metastasis	(Huang	and	
Rofstad,	 2018).	A	 clinical	 antibody	 called	Volociximab,	 that	 specifically	 binds	 to	a5b1,	
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showed	promising	results	in	initial	tests.	However,	its	development	was	stopped	during	
clinical	 trials	 due	 to	 lack	of	 efficiency	 (Raab-Westphal	 et	 al.,	 2017).	The	 small	 peptide	















more	 specific	 and	 effective	 drugs.	 However,	 because	 of	 their	 roles	 in	 various	 cellular	





Thus,	 elucidating	 the	 roles	 of	 integrins	 in	 a	 larger	 context	 is	 necessary.	 Most	 likely,	









Out	 of	 the	 over	 200	 proteins-containing	 integrin	 adhesome,	 only	 a	 variety	 of	
intracellular	proteins	are	involved	in	the	initial	integrin	activation	and	adhesion	assembly	
steps.	Two	major	FA	components	are	talin	and	kindlin,	which	are	both	able	to	activate	
integrins	by	 inside-out	activation	and	 further	 trigger	FA	assembly.	They	are	4.1-ezrin-
radixin-moesin	(FERM)	domain-containing	proteins	and	both	bind	to	the	CT	domain	of	
the	 b	 subunit	 of	 integrin.	 The	 CT	 domain	 contains	 two	 NxxY	 motifs:	 the	 membrane-
proximal	NPxY	motif,	which	is	recognized	by	talin,	and	the	membrane-distal	NxxY	motif,	
which	is	recognized	by	kindlin	(Moser	et	al.,	2009b).	Neither	talin	nor	kindlin	alone	are	
thought	 to	 activate	 integrins	by	 themselves,	 and	 are	 thus	 considered	 as	 co-dependent	
activators	(Moser	et	al.,	2009b).	The	binding	mode,	however,	still	remains	to	be	elucidated	
(Calderwood	 et	 al.,	 2013;	Moser	 et	 al.,	 2009b).	 It	 is	 unclear	whether	 talin	 and	 kindlin	
interact	directly	on	the	same	b-tail,	which	would	be	possible	since	they	bind	to	different	
motifs.	 Other	 possibilities	 include	 that	 they	 bind	 sequentially	 to	 the	 same	 tail	 or	






















mild	 defects,	 which	 hints	 at	 the	 fact	 that	 they	 might	 not	 be	 completely	 redundant	
(Debrand	et	al.,	2012).	
Talin	 consists	 of	 an	 N-terminal	 head	 and	 a	 C-terminal	 rod	 domain,	 which	 are	
connected	by	a	long	unstructured	linker	region	(Figure	7	A).	The	head	domain	of	talin	is	




located	 at	 the	 C-terminus	 (Calderwood	 et	 al.,	 2013;	 Gingras	 et	 al.,	 2008),	 which,	 in	
combination	 with	 some	 early	 EM	 studies,	 has	 suggested	 that	 talin	 might	 undergo	
homodimerization	(Goult	et	al.,	2013).	
As	 it	 is	 present	 in	 most	 integrin-based	 adhesions	 and	 crucial	 for	 inside-out	











Talin	 also	 contains	 a	 secondary	 integrin	 binding	 site	 in	 its	 rod	 domain	 (Figure	 7	 A);	
however,	its	relevance	and	specific	function	are	still	not	fully	understood	(Klapholz	and	
Brown,	2017).		







molecule	 are	 shielded	 from	 interaction	with	 other	 FA	 proteins	 (Klapholz	 and	 Brown,	
2017).	Mainly	the	interaction	between	F3	and	R9	is	of	importance,	as	it	protects	the	main	
integrin	binding	site	1	(IBS1)	in	the	talin	head	domain	(Figure	7	A).	
It	was	 suggested	by	different	 studies	 that	phosphatidylinositol	 4,5-biphosphate	
(PIP2)	helps	to	resolve	the	autoinhibiting	interaction	between	F3-R9	and	thus	might	open	
up	the	molecule	(Anthis	et	al.,	2009;	Goksoy	et	al.,	2008;	Goult	et	al.,	2009;	Song	et	al.,	
2012).	 Analysis	 of	 the	 talin	 head	 structure	 shows	many	 basic	 patches	 on	 the	 surface,	
which	 could	 facilitate	 orientation	 to	 the	 plasma	membrane	 as	 well	 as	 binding	 to	 the	
integrin	b	CT	(Elliott	et	al.,	2010).		
Upon	 opening	 of	 the	 molecule,	 talin	 connects	 to	 the	 actin	 cytoskeleton.	 As	 it	
contains	 three	 actin	 binding	 sites	 (ABS1-3),	 located	 in	 both	 head	 and	 rod	 domains	
(Calderwood	et	al.,	2013)	(Figure	7	A),	the	exact	sequential	steps	of	actin	binding	have	
been	 unclear	 for	 some	 time.	 A	 recent	 study	 has	 found	 that	 ABS3	might	 be	 the	 initial	
connection	 point	 to	 the	 actin	 cytoskeleton	 (Atherton	 et	 al.,	 2015).	 Upon	 binding	 to	
integrin	 and	 actin,	 talin	 extends	 to	 a	 60-100	 nm	 long	 fibrous	 strand	 (Liu	 et	 al.,	 2015;	









Post-translational	 mechanisms	 can	 control	 talin	 function	 as	 well.	 The	
phosphorylation	of	the	tyrosine	in	the	NxPY	motif	by	the	Src	family	kinase	has	been	shown	
to	switch	off	talin	binding	to	integrin	(Anthis	et	al.,	2009;	Oxley	et	al.,	2008).		
Other	 proteins	 involved	 in	 talin	 regulation	 are	 Rap1-GTP-interacting	 adaptor	
molecule	(RIAM),	which	helps	in	recruiting	talin	to	the	membrane,	where	it	is	displaced	
by	vinculin	(Goult	et	al.,	2013;	Lee	et	al.,	2013);	talin-activator	Kank	(Sun	et	al.,	2016b),	








structural	model	 of	 full-length	 talin	 has	 been	 hypothesized	 based	 on	 these	 individual	
domain	structures	(Figure	7	B).	In	our	recent	study,	we	have	determined	the	structure	of	
full-length	talin	1	by	employing	cryo-EM	(Dedden	et	al.,	2019).	This	structure	depicts	how	
the	 rod	 domains	 are	 arranged	 in	 autoinhibited	 talin,	 which	 shows	 a	 compact	




























and	 3,	 which	 exhibit	 varying	 expression	 patterns.	 Kindlin	 1	 is	 mainly	 expressed	 in	
epithelial	cells,	kindlin	3	in	hematopoietic	cells	while	kindlin	2	is	expressed	ubiquitously,	
except	for	hematopoietic	cells	(Moser	et	al.,	2009b;	Rognoni	et	al.,	2016).	Consistent	with	




































new	 cysteine-histidine-rich	 protein	 (PINCH)	 and	 parvin,	 forming	 the	 so-called	 ILK-
PINCH-parvin	(‘IPP’)	complex.	The	IPP	complex	helps	to	connect	integrin	further	to	the	
actin	cytoskeleton	(Mackinnon	et	al.,	2002;	Tu	et	al.,	2003).	Kindlin	can	also	recruit	several	
other	 FA	proteins	 such	 as	 actin-related	proteins	 2/3	 (Arp2/3)	 to	 FAs	 (Bottcher	 et	 al.,	
2017)	and	thus	act	as	a	signaling	hub	for	actin	cytoskeleton-linked	proteins	(Sun	et	al.,	
2019).	Furthermore,	 it	can	also	 interact	with	paxillin,	which	binds	to	FAK	and	triggers	
signaling	 pathways	 including	 Rho	 and	 Src	 signaling	 that	 ultimately	 affect	 cell	 fate	
(Huveneers	and	Danen,	2009;	Theodosiou	et	al.,	2016).		











Integrin	a5b1	is	 the	major	 fibronectin	binding	receptor	 in	the	human	body	and	
relevant	for	basic	cellular	processes	such	as	adhesion,	migration	and	development.		
Although	the	activation	mechanism	of	integrins	has	been	studied	extensively	in	the	
last	 decades,	 the	 molecular	 properties	 of	 all	 24	 integrins	 have	 been	 deduced	 and	
extrapolated	mostly	from	studying	a	few	specific	integrins,	i.e.	aIIbb3	and	avb3.	Thus,	the	
exact	mechanism	of	how	integrin	a5b1	and	fibronectin	interact	with	each	other	has	not	





particular,	 how	 exactly	 the	 interface	 between	 fibronectin	 and	 a5b1	 looks	 like,	 and	
whether	additional	interactions	are	present	next	to	RGD	and	synergy	sites.	In	addition,	
the	 role	 of	 physiological	N-glycosylation	patterns	 and	how	 they	 contribute	 to	 integrin	




In	 the	second	part	of	 this	 cumulative	 thesis,	 I	 contributed	 to	 the	structural	and	
biochemical	characterization	of	 the	 integrin	activator	 talin	1.	 In	 this	study,	 talin	1	was	
purified	and	subjected	to	biochemical	studies	as	well	as	structural	analysis	by	cryo-EM.	
The	findings	shed	light	on	how	autoinhibition	is	achieved	in	full-length	talin	1.	Mainly,	it	
is	 analyzed	 how	 the	 integrin,	membrane-binding,	 actin	 and	 vinculin	 binding	 sites	 are	
shielded	in	the	entangled	structural	organization.	The	results	suggest	how	talin	is	kept	



















role	 of	 N-glycosylation	 in	 integrin	 activation	 is	 elucidated.	 Interestingly,	 the	 inactive	
conformation	of	integrin	a5b1	shows	a	novel,	incompletely	bent	arrangement,	which	has	
not	 been	 observed	 previously	 for	 other	 integrins.	 Overall,	 this	 study	 provides	 new	
insights	 into	 integrin	 a5b1	 function	 and	 shows	 that	 a5b1	 adopted	 an	 activation	
mechanisms	that	is	different	from	other	well-studied	integrins	such	as	aIIbb3	or	avb3.	
	
The	 study	 was	 conducted	 under	 the	 supervision	 of	 Naoko	 Mizuno	 at	 the	 Max	
Planck	 Institute	 of	 Biochemistry	 in	Martinsried,	 Germany.	 I	 performed	 purification	 of	




































Integrin	a5b1	 is	a	major	 fibronectin	receptor	critical	 for	cell	migration.	Upon	complex	
formation,	fibronectin	and	a5b1	undergoes	a	compelling	conformational	change	for	their	
engagement.	Here,	we	 report	 cryo-EM	structures	of	native	human	 integrin	α5β1	 in	 its	
open	conformation	with	fibronectin	and	TS2/16	antibody	to	3.1Å,	and	in	its	resting	state	
to	 4.6Å	 resolution.	 The	 α5β1-fibronectin	 revealed	 synergistic	 interactions	 at	 the	 RGD	
loop,	 the	 synergy	 site	 and	 juxta-RGD,	 proximal	 to	 the	 integrin	metal	 ion	 binding	 site	
ADMIDAS.	In	its	resting	state,	α5β1	employs	a	half-closed	conformation,	challenging	the	
traditional	 model	 of	 bent/open	 conformations	 tightly	 coupled	 to	 ligand	 affinity.	 Our	
biochemical	and	structural	analyses	revealed	that	Mn2+	increases	the	affinity	of	α5β1	for	
fibronectin	while	still	in	its	half-bent	conformation	and	only	as	a	result	of	ligand-binding,	








the	 communication	 between	 cells	 and	 extracellular	matrix	 (ECM).	 Furthermore,	 α5β1	
represents	 an	 integrin	 prototype	 that	 is	 fundamental	 to	 cellular	 processes,	 yet	 its	
crosstalk	with	FN,	 the	major	 component	of	 the	 extracellular	matrix	 (ECM),	 is	not	well	
understood.		
Serving	as	a	direct	bidirectional	link	between	the	cell	and	its	environment,	integrin	α5β1	






ECM,	 through	 its	 extracellular	 domains	 and	 to	 the	 actin	 cytoskeleton	 through	 its	
cytoplasmic	tail	domain	(Campbell	and	Humphries,	2011).	Failure	of	integrin	function	and	
corresponding	 impairment	 of	 the	 focal	 adhesion	 machinery	 is	 related	 to	 numerous	
diseases	 (Winograd-Katz	 et	 al.,	 2014),	 including	 aggressive	 cancer	 formation	 due	 to	







termed	ectodomain,	via	 the	common	 integrin	 ligand	motif	 ‘Arginine-Glycine-Aspartate’	
(RGD)	 in	 the	 FN10	 domain.	 During	 cell	 movement,	 as	 bound	 integrin	 is	 exposed	 to	
mechanical	 force,	 it	 grips	 FN	 through	 its	 so-called	 synergy	 site	 with	 a	 sequence	 of	
DRVPHSRN	 in	 FN9	 domain	 (Leahy	 et	 al.,	 1996;	 Wierzbicka-Patynowski	 and	
Schwarzbauer,	 2003)	 and	 anchors	 cells	 with	 unknown	 mechanism.	 How	 FN	 engages	
integrin	α5β1	and	activates	cells	remains	enigmatic.	
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2011;	Takagi	 et	 al.,	 2002;	Xie	 et	 al.,	 2010;	Xiong	 et	 al.,	 2001;	 Zhu	 et	 al.,	 2008).	 In	 this	
unprimed	state,	integrins	show	low	affinity	for	their	ligands	with	their	heads	occluding	
access	 to	 the	 ligand	 binding	 stie	 by	 facing	 to	 the	 plasma	 membrane	 (Campbell	 and	
Humphries,	 2011;	 Luo	 et	 al.,	 2007).	 In	 the	 presence	 of	 Mn2+,	 mimicking	 intracellular	
signals,	 classical	 integrins	 become	 ‘primed’,	 and	 show	 an	 increased	 affinity	 for	 their	




integrin	 heads	 (Xiao	 et	 al.,	 2004;	 Xiong	 et	 al.,	 2002;	 Zhu	 et	 al.,	 2013)	 translates	
conformational	 changes	 from	 the	 metal-ion-dependent	 adhesion	 site	 (MIDAS)	 to	 the	
allosteric	 swing-out	motion	 of	 the	 b	 hybrid	 domain	 (Luo	 et	 al.,	 2007),	 leading	 to	 the	
opening	of	the	legs.	However,	this	mode	of	action	does	not	apply	to	integrin	α5β1.	Majority	
of	 truncated	 integrin	 α5β1	 does	 not	 undergo	 the	 large	 conformational	 change	 in	 the	
presence	 of	 RGD	 peptide	 alone	 (Takagi	 et	 al.,	 2003);	 moreover,	 negative-stain	 EM	
observations	of	 its	 resting	state	hinted	at	 incomplete	bending	of	 the	α5β1	ectodomain	
(Miyazaki	et	al.,	2018),	which	challenges	the	view	that	bending	secures		the	inhibition	of	
ligand	 attachments.	 These	 observations	 raised	 the	 question	 whether	 integrin	 α5β1	
employs	a	unique	mechanism	with	only	weak	coupling	between	its	global	conformational	
change	 and	 its	 ligand	 binding	 affinity.	 Considering	 its	 critical	 biological	 roles	 in	 cell	
attachment	and	metastatic	detachment,	it	is	imperative	to	uncover	how	the	activation	of	
α5β1	differs	from	the	canonical	model,	and	how	FN	crosstalks	with	α5β1.		
Here,	we	 report	 the	 cryo-EM	 structures	 of	 native	 human	 integrin	 α5β1	 purified	 from	
human	placenta	in	1)	its	fully	extended	open	conformation	in	complex	with	FN	and	the	
stabilizing	 antibody	 TS2/16	 and	 2)	 in	 its	 resting	 state	 employing	 only	 a	 half-bent	
conformation.	 Using	 non-recombinant	 full-length	 native	 integrin	 ensures	 the	
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physiological	 relevance	of	 the	novel	half-bent	 structure.	The	complex	of	 integrin	α5β1	






















al.,	 1987)	 and	 embedded	 into	 membrane-scaffolding	 nanodiscs	 (Fig.	 S1B	 and	 S1C)	
(Denisov	et	al.,	2004).	To	understand	the	 integrin	opening	and	 ligand	engagement,	we	




























Integrin	was	 purified	 from	 a	 natural	 source,	 allowing	 us	 to	 evaluate	 the	 physiological	
relevance	 of	 post-translational	 modifications,	 particularly	 glycosylation	 (Fig.	 2).	 The	
identified	N-glycosylation	sites	(Fig.	2A)	validated	the	previous	structural	visualizations	
of	 recombinantly	 prepared	 samples	 (Nagae	 et	 al.,	 2012;	 Xia	 and	 Springer,	 2014),	 and	






and	 an	 N-acetylglucosamine	 moiety,	 respectively.	 S223	 (α5)	 further	 restricted	 the	




engaged.	 Our	 structure	 offers	 a	 direct	 structural	 explanation	 of	 why	 glycosylation	 is	







3D).	 The	 RGD	motif	 located	 within	 a	 loop	 of	 FN10	 interlocks	 deeply	 into	 the	 pocket	
between	the	α	and	β	integrin	-subunits	with	a	stable	conformation	(Fig.	3A,	3B	and	3C).	
This	loop	was	previously	shown	to	be	flexible	in	an	isolated	FN10	domain	by	NMR	(Main	
et	 al.,	 1992).	 The	 arrangement	 of	 the	 loop	 in	 the	 complex	 structure	 resembles	 that	 of	
single	RGD	peptides	bound	to	the	headpiece	of	a5b1	(Fig.	3E,	(Xia	and	Springer,	2014)).	









the	separation	of	 the	α-	and	β-	 legs	 (Campbell	and	Humphries,	2011;	Luo	et	al.,	2007;	
Takagi	et	al.,	2002;	2003;	Zhu	et	al.,	2008;	2013).	Our	structure	also	showed	engagement	
of	the	ligand	RGD	motif	with	MIDAS	(Fig.	3B),	and	the	resulting	open-leg	conformation	
(Fig.	 1).	 This	 reinforces	 the	 notion	 that	 various	 integrin	 isotypes	 share	 a	 common	
molecular	movement	in	which	the	interaction	with	ligands	or	ligand-mimetics	at	MIDAS	















its	 upstream	portion	 closer	 to	 FN	 (Fig.	 3F),	 facilitating	 a	 large	 tilt	 of	 the	 β-	 head.	 The	
importance	of	that	interaction	is	supported	by	a	previous	report	that	an	R1445A	mutant	
displayed	drastic	reduced	cellular	adhesion	(Redick	et	al.,	2000).	Together,	the	observed	
arrangement	of	FN10	R1445	and	Y1446	at	ADMIDAS,	 together	with	 the	RGD	 loop	and	








helix	 is	 formed	 immediately	 after	 the	 proTGF-β1	 RGD	 motif.	 The	 helix	 then	 forms	
hydrophobic	interactions	with	integrin,	which	appears	to	be	the	key	interactions	to	move	
the	 specificity-determining	 loop	1	 (SDL1),	which	 is	 the	 loop	 upstream	of	 the	a1	helix	
(Dong	et	al.,	2017).	Furthermore,	proTGF-	β1	recognizes	integrin	β6	SDL2	as	a	secondary	
interaction	 surface	 (Dong	 et	 al.,	 2017).	 In	 contrast,	 the	 SDL2	 (residues	 176-195)	 of	
integrin	β1	did	not	exhibit	interaction	with	FN	(Fig.	S4).	In	the	case	of	a6b1-laminin,	the	
multiple	contacts	of	each	laminin	subunit	stabilized	the	formation	of	the	open	groove	of	
the	a6b1	heads	 (Arimori	 et	 al.,	 co-submitted	with	 this	manuscript).	 In	both	 cases	and	





Y208	 in	 a5	 (Fig.	 3D).	 Particularly,	 the	 R1379-D154	 interaction	 agrees	 with	 previous	
biochemical	identifications	of	D154	as	a	key	residue	for	interaction	with	the	synergy	site	





















TS2/16	 recognizes	 integrin	 α5β1	 without	 interfering	 with	 key	 residues	 for	
conformational	change	
TS2/16	 is	 a	 stimulatory	 antibody	 that	 recognizes	 the	 head	 domain	 of	 the	 β1	 subunit	
(reviewed	in	(Byron	et	al.,	2009)).	It	is	reported	to	reduce	the	off-rate	of	integrin-ligand	












To	understand	 the	conformational	 change	of	 integrin	α5β1	and	 its	 consequence	 to	FN	
binding,	we	obtained	the	cryo-EM	structure	of	integrin	α5β1	in	its	resting	conformation	







(Miyazaki	 et	 al.,	 2018;	 Su	 et	 al.,	 2016).	 Compared	 with	 the	 ligand-bound	 open	
conformation	of	 integrin	α5β1,	 the	 lower	 legs	of	both	 the	a-	and	b-subunits	 in	resting	
integrin	were	less	flexible,	enough	to	be	clearly	visible.	That	is	likely	because	of	parallel	
closure	of	the	α	-	and	β	-	legs	(Fig.	4G),	while	in	the	open	conformation	the	contact	points	
of	the	 legs	are	 lost	as	a	result	of	the	opening	of	the	upper	 legs.	That	shows	that	 ligand	
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resolving	 the	 side	 chains	 (Fig.	 S5D).	 The	 integrin	 heads	 were	 tilted	 in	 the	 closed	












which	 were	 aligned	 in	 parallel	 similarly	 to	 the	 available	 structures	 of	 acutely	 bent	
integrins	 (Xiong	 et	 al.,	 2001;	 Zhu	 et	 al.,	 2008).	 Subsequent	 multibody	 analysis,	














Mn2+	 is	 necessary	 for	 integrin	 α5β1	 ligand	 binding	 but	 does	 not	 induce	 large	
conformational	change		
To	closely	follow	the	key	steps	leading	from	the	resting	to	the	fully	open	conformation	of	
integrin	α5β1,	we	 investigated	 the	 conformations	of	 integrin	 in	 the	presence	of	buffer	
containing	various	concentrations	of	Mn2+.	Cryo-EM	analysis	showed	that	integrin	α5β1	
employed	the	half-bent	resting	conformation	even	at	the	extreme	concentration	of	100	




subunit.	That	 is	 in	stark	contrast	to	aIIbb3,	 for	which	either	Mn2+	or	 ligand-mimicking	
peptide	was	sufficient	to	induce	full	opening	(Eng	et	al.,	2011).		
Those	 findings	 led	 us	 to	 hypothesize	 that	 the	 large	 conformational	 change	 of	 integrin	
α5β1	is	only	stabilized	as	a	result	of	FN	binding,	rather	being	the	cause	of	FN	binding.	To	
test	that,	we	performed	solid-phase	equilibrium	binding	assays	(Fig.	6B).	For	that	ELISA-
like	 assay,	wells	were	 coated	with	 full-length	 FN,	 and	 the	 binding	 of	 α5β1	 to	 FN	was	









Furthermore,	 to	 systematically	 survey	 the	 global	 conformations	 of	 integrin	 α5β1,	 we	
performed	reconstitution	assays	using	size-exclusion	chromatography	(SEC)	followed	by	
surveillance	of	the	conformations	using	negative-stain	EM	(Fig.	7).	While	vitrified	integrin	
samples	 for	 cryo-EM	 are	 instrumental	 in	 structural	 analyses	 of	 robustly	 folded	
populations,	 negative-stain	 EM	 allows	 the	 visualization	 of	 flexible	 entities	 that	 do	 not	
align	well	because	of	the	low	signal-to-noise	ratio	of	cryo-EM	images,	and	would	therefore	









blue	 lines,	peak	marked	with	*),	whereas	no	binding	 took	place	without	Mn2+	 (7A,	 left	
side).	 Subsequent	 negative-stain	 EM	 observation	 and	 conformational	 assessment	
revealed	an	 increase	 in	 the	proportion	of	molecules	 in	 the	open	conformation	(41	%),	
compared	with	that	in	the	same	condition	without	Mn2+	(0	%)	or	without	FN7-10	but	with	












human	 integrin	 α5β1	 from	 a	 natural	 source	 (human	 placenta)	 and	 reconstituted	 the	
complex	with	FN	in	a	membrane	scaffold	to	facilitate	a	comprehensive	biochemical	and	
structural	 analysis.	 Our	 strategy	 has	 two	 important	 advantages:	 1)	 Our	 results	 were	
obtained	with	native	proteins	in	a	biologically	relevant	context	and	2)	We	were	able	to	










to	extend	and	open	 the	α5β1	 legs	 (Fig.	1	and	5A).	To	date,	 two	examples	of	 truncated	
integrins	bound	to	their	protein	ligands	have	been	reported,	namely	αVβ6-proTGF-b1	and	
αVβ8-proTGF-b1.	While	αVβ6	opens	its	α-	and	β-	subunits	 in	complex	with	proTGF-b1	
(Dong	 et	 al.,	 2017),	 αVβ8	 does	 not	 open	 its	 legs	 even	 upon	 ligand	 binding,	 and	 its	
ADMIDAS	 does	 not	 contain	 any	 metal	 ion	 (Campbell	 et	 al.,	 2020).	 Together,	 those	
observations	implicate	the	importance	of	ADMIDAS	for	the	opening	of	integrins.	On	the	
other	 hand,	 the	 synergy	 site	 is	 reported	 to	 be	 responsible	 for	 the	 force-induced	






together	with	 our	 cryo-EM	pipeline,	 allowed	 us	 to	 investigate	 the	 stepwise	molecular	
	 53		
response	 during	 integrin	 α5β1	 ligand	 engagement.	 Our	 analysis	 revealed	 that	 the	




means	 that	 FN-binding	 does	 not	 require	 prior	 opening,	 but	 instead,	 the	 open	
conformation	 of	 α5β1	 becomes	 dominant	 as	 a	 result	 of	 the	 FN-binding.	 We	 further	
showed	 that	binding	of	Mn2+	 is	 key	 to	 facilitate	 the	 interaction	between	FN	and	α5β1	
without	 altering	 the	 conformational	 dynamics.	We	 surmise	 that	 Mn2+-coordination	 at	
ADMIDAS	 might	 play	 a	 critical	 role	 in	 increasing	 the	 affinity	 for	 FN.	 Once	 the	 juxta-
ADMIDAS	FN-binding	site	is	primed,	FN	may	engage	the	three	binding	sites	on	the	integrin	
surface.	That	binding	fosters	the	translocation	of	ADMIDAS,	which	then,	together	with	the	











bent	 conformation	 of	 α5β1	 is	 still	 physically	 accessible	 to	 FN,	 but	 a	 breathing	motion	
towards	extension	might	increase	the	probability	of	docking	of	the	three	interaction	sites	
to	FN.	Finally,	when	FN	binds,	integrin	α5β1	is	globally	extended	with	its	legs	open,	which	
is	 facilitated	 by	 the	 movement	 of	 the	 helix	 α7	 along	 with	 local	 rearrangements	 near	
ADMIDAS,	and	further	by	the	molecular	constraint	of	the	beads-on-string	arrangement	of	
FN9-10.	 Overall,	 it	 is	 intriguing	 that	 the	 ligand	 recognition	 mechanisms	 of	 integrin	








makes	 the	 ligand	 binding	 surface	 inaccessible	 because	 of	 its	 proximity	 to	 the	 plasma	
membrane.	 However,	 in	 the	 case	 of	 β1	 integrin,	 the	most	 prominent	 integrin	 subunit	
dimerizing	with	12	different	a	subunits	(Hynes,	2002),	it	was	hinted	by	negative-stain	EM	
that	the	conventional	open-bent	model	deduced	from	the	behavior	of	β3	integrin	might	
not	 be	 applicable	 	 (Miyazaki	 et	 al.,	 2018).	 We	 directly	 showed	 that	 the	 resting	
conformation	of	integrin	α5β1	is	only	half-bent	with	a	90˚	angle	between	the	headpiece	
and	the	legs	(Fig.	4	and	S7).	A	higher-resolution	structures	of	the	lower	leg	is	needed	to	
elucidate	 the	precise	molecular	mechanism	of	 that	angular	arrangement.	 Interestingly,	




extended	 conformation	 is	 advantageous	 for	 searching	 and	 binding	 to	 its	 ligands	 and	
subsequent	cellular	activation	(Campbell	et	al.,	2020;	Cormier	et	al.,	2018).	In	contrast,	
αIIbβ3	is	enriched	on	the	surface	of	platelets,	and	there	is	a	clear	distinction	between	its	
closed-inaccessible	 and	 open-extended	 conformations,	 because	 the	 aggregation	 of	
platelets	has	to	be	tightly	regulated	to	avoid	detrimental	effects	on	blood	circulation.	On	
the	 other	 hand,	 α5β1	 is	 ubiquitously	 expressed	 throughout	 various	 tissues	 and	 is	
generally	involved	in	cellular	responses	that	are	slower	than	those	of	the	immune	system.	
Therefore,	the	loose	closure	of	α5β1	might	reflect	that	functional	aspect	and	thus	provide	
a	 less	 acute	 response	 to	 extracellular	 cues.	Altogether,	 the	differences	 among	 integrin	




We	 demonstrated	 a	 stepwise	 mechanism	 of	 large	 conformational	 change	 in	 α5β1		
(summarized	in	Fig.	8).	However,	in	a	cellular	context,	different	intracellular	factors,	such	




















and	 integrin	 α5β1	 in	 the	 absence	 of	 force,	 which	 can	 be	 used	 as	 a	 basis	 for	 further	
analyses.	
FN	acts	as	a	dimer	 in	 its	 full-length	context	and	polymerizes	 into	a	 fibrous	 form	when	
integrated	 in	 the	 ECM	 network.	 The	 polymerization	 is	 induced	 by	 interaction	 with	
integrin	a5b1	(Sechler	et	al.,	1997).	In	turn,	the	FN	within	the	ECM	might	also	act	as	a	
platform	 to	 induce	 integrin	 clustering,	 which	 contributes	 to	 stabilize	 the	 large	
intracellular	multi-layered	focal	adhesion	machinery	consisting	of	hundreds	of	proteins	
(Zaidel-Bar	et	al.,	2007).	Furthermore,	the	phenomenon	of	molecular	breathing	has	been	
observed	 for	 the	 intracellular	 focal	 adhesion	 proteins	 talin	 (Dedden	 et	 al.,	 2019)	 and	
vinculin	(Kelley	et	al.,	2020),	which	together	with	integrin,	may	play	an	important	role	in	
the	dynamic	behaviors	of	focal	adhesions.	Molecular	breathing	might	be	advantageous	in	
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centrifugation	 at	 12,000g	 for	 15	 min	 at	 4	°C	 (Beckmann	 centrifuge,	 J14	 rotor).	 The	
supernatant	was	then	sonicated	(Vs70T,	Bandelin)	and	centrifuged	again	at	10,000g	for	


















Hybridomas	 expressing	 the	 KH72	 monoclonal	 antibody	 were	 kindly	 gifted	 by	 Dr.	 K.	
Miyake	(University	of	Tokyo).	Cells	were	cultured	in	RPMI	1640	medium	(Gibco,	with	25	
mM	HEPES	and	L-glutamine)	 supplemented	with	10%	 fetal	 bovine	 serum,	0.1	mg/mL	
kanamycin,	2	mM	L-glutamine,	and	10	µM	b-mercaptoethanol.	The	cells	were	grown	at	37	
	 58		
°C	with	5%	CO2	 in	T125	 flasks	 and	were	 split	 at	 confluency	every	2–3	days	by	gently	









(pH	8.8)	 and	150	mM	NaCl.	Bound	protein	was	eluted	with	 low-pH	 IgG	elution	buffer	
(Pierce,	 ThermoFisher)	 and	 collected	 in	 1	 mL	 fractions,	 which	 were	 immediately	


















phenylmethylsulfonyl	 fluoride	 (PMSF).	 After	 removal	 of	 debris	 by	 centrifugation	 at	
20,000g	for	30	min	at	4	°C	(Beckmann	centrifuge,	JA	25.50	rotor),	the	supernatant	was	







SDS-PAGE,	were	pooled	 and	 concentrated	using	 an	Amicon	ultrafiltration	device	 (10K	
MWCO),	and	the	buffer	was	exchanged	through	SEC	to	20	mM	Tris	(pH	7.4),	100	mM	NaCl,	





























SARAH	 and	 VL-SARAH	 fragments	 were	 individually	 expressed	 in	 Bl21	 gold	 DE3	 cells	
grown	 in	 LB	 medium.	 The	 cells	 were	 grown	 until	 the	 OD600	 reached	 ~0.6	 at	 37	 °C.	
Expression	was	then	induced	by	incubation	with	0.4	mM	IPTG	for	4	h	at	37	°C.	The	TS2/16	



















protocol	 (Denisov	 et	 al.,	 2004)	with	 the	 following	 adaptations.	 Isoform	MSPE3D1	was	
used	for	all	experiments,	except	that	we	used	MSP∆H5	to	test	the	effects	of	different	Mn2+	
concentrations	on	the	integrin	conformation	in	cryo-EM	(Fig.	6A).	Lipid	stock	(from	Folch	
fraction	I,	 bovine	 brain,	 Sigma)	 was	 stored	 in	 chloroform:methanol:H2O	 (20:9:1)	 at	 a	
concentration	of	25	mg/mL	at	-20	°C.	Before	use,	the	required	amount	of	lipid	was	dried	








CaCl2.	 The	peak	 containing	ND	with	 inserted	a5b1	 (ND–a5b1;	 as	 determined	by	 SDS-
PAGE	and	negative-stain	EM)	was	then	pooled,	concentrated	(Amicon,	50K	MWCO)	at	a	











or	 TBS	 (pH	 7.5)	 and	 1	 mM	MnCl2.	 The	 mixture	 (total	 volume	 50	 µL/well)	 was	 then	
incubated	for	3	h	at	room	temperature.	The	wells	were	then	washed	three	times	with	200	
µL/well	 of	 the	 respective	 buffers	 (containing	 either	 MgCl2/CaCl2	 or	 MnCl2),	 and	 50	




added	 to	 bring	 the	 total	 volume	 to	 50	 µL/well.	 After	 incubation	 for	 1	 h	 at	 room	
temperature,	 the	 wells	 were	 washed	 four	 times	 with	 200	 µL/well	 of	 the	 respective	
buffers,	 and	 100	 µL/well	 ABTS/H2O2	 solution	 (Sigma,	 ready-to-use)	 was	 added.	
Absorption	at	420	nm	was	measured	6	min	after	the	addition	of	ABTS/H2O2	using	a	plate	






To	 assess	 the	 binding	 between	 ND-a5b1	 and	 FN7–10	 in	 the	 presence	 or	 absence	 of	
TS2/16	Fv-clasp,	 the	 reaction	 components	were	mixed,	 incubated,	 and	 injected	 into	 a	
Superose	6i	column	(S6i,	3.2/300	on	ÄKTAmicro	system	(GE)),	either	in	TBS	(pH	7.5),	1	













µg/mL)	 was	 incubated	 on	 glow-discharged	 carbon-coated	 copper	 grids	 (homemade	
carbon	layer)	for	1	min	at	room	temperature	and	then	washed	twice	in	100	µl	drops	of	
H2O.	Excess	H2O	was	removed	by	touching	the	rim	of	the	grids	with	blotting	paper.	The	





defoci	 from	 -1.5	 µm	 to	 -2.5	 in	 0.5	 µm	 steps	 at	 an	 exposure	 of	 4	 s	 with	 10	
frames/micrograph	and	a	total	dose	of	105	e/Å2.	Recorded,	gain-normalized	frames	were	
aligned,	motion	corrected,	and	dose-weighted	using	MotionCor2	software	(Zheng	et	al.,	
2017).	 Defocus	 values	 were	 assessed	 using	 either	 GCTF	 (Zhang,	 2016)	 or	 CTFFIND4	




as	 templates	 for	 automated	 picking	 with	 Gautomatch	 software	 (https://www2.mrc-
lmb.cam.ac.uk/research/locally-developed-software/zhang-software/).	 For	 all	






































After	 a	3D	classification	 run	using	 the	 initial	model	 as	 a	 reference,	 out	of	8	 generated	
classes,	 the	 reconstruction	 with	 the	 most	 prominent	 features	 (16,765	 particles)	 was	
selected	as	an	initial	reference	for	3D	reconstruction	of	the	dataset	of	FN-bound	integrin	
a5b1	for	high-resolution	analysis,	as	described	below.	



















software	 and	 a	 Talos	 Arctica	 with	 a	 Falcon	 3	 direct	 detector	 with	 the	 following	
parameters:	nano-probe	mode,	operating	voltage	200	kV,	92,000×	magnification	 (1.61	
Å/pix),	 varying	 defoci	 from	 -2	 µm	 to	 -3	 µm,	 0.5	 µm	 steps,	 exposure	 of	 3	 s,	 40	
frames/micrograph,	and	total	dose	67	e/Å2.	The	recorded,	gain-normalized	frames	were	
	 65		
aligned,	motion	 corrected,	 and	dose-weighted	 using	MotionCor2.	Defocus	 values	were	
assessed	using	CTFFIND4.	A	total	of	965	and	88	micrographs	were	acquired	for	10	mM	
Mn2+	 and	 100	 mM	 Mn2+,	 respectively.	 Automated	 picking	 with	 Gautomatch	 was	
performed,	and	202,156	and	18,822	particles	were	picked	for	10	mM	Mn2+	and	100	mM	


















sample	preparation,	such	as	 the	 interaction	of	 the	membrane	scaffolding	with	 the	air–
water	 interface.	 That	 interaction	 in	 particular	 is	 known	 to	 cause	 local	 instability	 on	
embedded	proteins	during	cryo-EM	sample	preparation,	which	might	cause	the	integrin	
to	 become	 separated	 from	 the	 membrane	 scaffold.	 Therefore,	 the	 remaining	










For	 the	 resting	 integrin	 a5b1	 dataset	 (Fig.	 4),	 2818	 micrographs	 were	 recorded	 at	
105,000×	magnification	(0.85	Å/pixel)	in	counting	mode	with	varying	defoci	from	-0.5	µm	
to	-3.2	µm	in	0.3	µm	steps	at	a	total	dose	of	either	65.8	e/Å2	(2	s	exposure,	20	frames,	3.13	
e/Å2	 frame	dose)	or	82.3	e/Å2	 (2.5	s	exposure,	50	 frames,	1.65	e/Å2	 frame	dose).	The	
frames	of	the	combined	micrographs	were	gain-normalized,	motion	corrected,	aligned,	








was	 the	reconstruction	obtained	 from	the	screening	dataset,	which	was	 then	 low-pass	
filtered	 to	30	Å.	The	98,750	particles	with	 the	most	prominent	 features	were	selected	
from	 the	 reconstruction	 for	 further	 processing.	 Those	 particles	 were	 rescaled	 to	 the	
original	box	size	of	300	and	further	refined	in	the	RELION3	processing	pipeline,	resulting	
in	the	final	density	map	of	the	whole	molecule	with	6.2	Å	total	resolution,	as	determined	
by	 the	 gold-standard	 Fourier	 shell	 correlation	 criterion	 (FSC=0.143)	 in	 the	 RELION3	
postprocessing	 option.	 Using	 Chimera	 (Pettersen	 et	 al.,	 2004)	 and	 the	 implemented	
Segger	plugin	(Pintilie	et	al.,	2010;	2009),	the	map	of	the	whole	molecule	was	divided	into	
the	headpiece	and	 the	 lower	 legs	 (see	Fig.	S6)	and	 then	 low-pass	 filtered	 to	15	Å.	The	




orientations	 as	 determined	 by	 Multibody	 refinement	 into	 account.	 With	 focused	 3D	










automatically	 performed	 on	 a	 GPU	 workstation	 running	 the	 modular	 Focus	 software	
(Biyani	 et	 al.,	 2017).	 Those	 steps	 included	 gain	 normalization,	motion	 correction,	 and	
dose-weighting	 by	 MotionCor2;	 CTF	 estimation	 by	 GCTF;	 and	 particle	 picking	 by	
Gautomatch,	using	a	template	obtained	from	a	the	screening	dataset	of	the	same	sample	
(see	above).	A	total	of	4,218,951	particles	were	boxed	out	with	a	box	size	of	360	pixels,	
















whole	 molecule	 as	 a	 reference	 and	 applying	 the	 mask	 of	 the	 ‘core’.	 That	 procedure	




To	 prepare	 an	 initial	 model	 of	 the	 FN-bound	 and	 TS2/16-bound	 integrin	 a5b1,	 the	
available	crystal	structures	4wk0	(a5b1	headpiece	(Xia	and	Springer,	2014)),	3vi3	(a5b1	








added,	 and	 the	 structure	was	 validated	using	PHENIX	 (Afonine	 et	 al.,	 2018).	The	 final	




3vi3	 (Nagae	 et	 al.,	 2012)	 showing	 the	 headpiece	 and	 headpiece	 with	 upper	 legs,	
respectively,	were	used	for	initial	fitting	in	CHIMERA.	The	missing	parts	of	the	lower	legs	
(calf	1	and	2,	PSI,	EGF	1-4,	and	b-tail	domains)	were	prepared	by	homology	modeling	










Figure	 1:	 Cryo-EM	 analysis	 of	 FN-bound	 integrin	 a5b1	 reveals	 an	 open	
conformation.	
A:	Two	views	of	the	FN7-10	(orange)	-bound	a5b1	(green	-	a	subunit,	blue	-	b	subunit)	














































































Figure 3: Binding of integrin α5β1 to FN7-10 occurs through an 










































































































B:	The	RGD	 loop	of	FN10	 is	 inserted	 into	 the	binding	pocket	between	the	a5-	and	b1-	
























A-C:	 Three	 views	 of	 the	 resting	 integrin	a5b1	 cryo-EM	 structure.	 The	 position	 of	 the	
membrane	is	indicated	in	yellow.		
D-F:	The	structure	of	the	headpieces	and	modeled	structure	using	homology	models	of	

































































B:	 Solid-phase	 binding	 assays	 to	 measure	 integrin	 binding	 to	 full-length	 FN	 in	 the	
presence	 of	 activating	 (Mn2+)	 or	 resting	 (Ca2+/Mg2+)	 buffer	 conditions	 and	 varying	
integrin	 a5b1	 concentration.	 The	 principle	 of	 the	 assay	 is	 shown	 on	 the	 right.	 ND:	






be	 altered	by	 a	 combination	of	 ligands	 and	 stabilizing	 factors	Mn2+,	 FN7-10	 and	
TS2/16.	
A.	FN7-10	binding	to	a5b1	was	tested	by	SEC	in	resting	(Ca2+/Mg2+)	and	activating	(Mn2+)	
buffer	 conditions.	 In	 the	presence	 of	Mn2+,	 FN7-10	binding	 could	be	detected	by	 SDS-









Particles	were	 sorted	 into	 three	 states:	 ‘bent’,	 ‘intermediate’,	 and	 ‘separated	 legs’.	 For	
each	condition,	~20000	particles	were	initially	picked,	and	those	displaying	a	clear	signal	






Integrin	 a5b1	 exists	 in	 an	 equilibrium	 of	 conformational	 states,	 fluctuating	 between	


























































S1: Purification of integrin α5β1 from human placenta and 
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B:	 The	 FSC	 curve	 of	 the	 whole	 molecule	 revealing	 the	a5b1	 headpiece,	 FN7-10,	 and	
TS2/16,	left:	shows	a	global	resolution	of	3.5	Å.	The	FSC	curve	of	the	core	(a5b1	head,	
FN9-10,	TS2/16),	right:	after	focused	refinement	shows	a	global	resolution	of	3.1	Å.	







9431 micrographs collected, 
Initial processing steps performed automatically via Focus software, including:
Frame alignment and motion correction via MotionCor2,
Defocus estimation by GCTF,
4218951 particles picked via automated picking by Gautomatch
1492856 particles
680610 particles
3 rounds of 2D classification in RELION
1 round of 3D classification in RELION
3D template 
3D Refinement in RELION
Final map of whole molecule: 3.5 Å
Focused refinement 
with partial signal subtraction 
of flexible domains (RELION)
Final map of core region: 3.1 Å
S3: Details of the data processing scheme that resulted in the 


















S4: Integrin α5β1 and αvβ6 recognize their ligands in different 
ways. 







S5: Single-particle cryo-EM analysis of resting integrin α5β1. 
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A	 Left:	 Representative	 cryo-EM	 image	 of	 resting	 integrin	 a5b1	 and	 Right:	 2D	 class	
averages.	
B:	The	FSC	curve	of	the	whole	molecule	(a5b1	ectodomain,	left)	shows	a	global	resolution	
of	 6.2	 Å.	 The	 FSC	 curve	 of	 the	 a5b1	 headpiece	 (right)	 after	 Multibody	 and	 focused	
refinement	shows	a	global	resolution	of	4.6	Å.	









Frame alignment and motion correction via MotionCor2,
Defocus estimation by GCTF or CTFFIND4,
496356 particles picked via automated picking by Gautomatch
255514 particles
98750 particles
1 round of 2D classification in RELION
1 round of 3D classification in RELION
3D template
3D Refinement in RELION
Map of whole molecule: 6.2 Å
Multibody refinement (RELION) 
and subsequent 
focused refinement 
with partial signal subtraction 
of flexible domains 
Map of whole molecule, recombined
Map of core region: 4.6 Å Map of flexible lower half: 8 Å
S6: Details of the data processing scheme that resulted in 




Graphical	 summary	 of	 the	 data	 processing	 scheme	 for	 resting	 a5b1.	 Out	 of	 496,356	
automatically	 picked	 particles,	 98,750	 particles	 were	 selected	 after	 2D	 and	 3D	
classification	in	RELION3.	Those	particles	resulted	in	the	map	of	the	whole	molecule	with	


















































































































































































































































the	 key	 adhesion	 protein	 and	 integrin	 activator	 talin	 1.	 In	 this	 study,	 we	 solved	 the	
structure	of	full-length	talin	1	in	its	autoinhibited	state	by	cryo-EM.	The	arrangement	of	
the	molecule	revealed	how	integrin-,	membrane-	and	actin-binding	sites	within	talin	are	
shielded	 in	 the	 compact	 structure,	 which	 was	 confirmed	 by	 further	 biochemical	
experiments.	
	
The	 study	 was	 performed	 under	 the	 supervision	 of	 Naoko	Mizuno	 at	 the	 Max	
Planck	 Institute	 of	 Biochemistry	 in	Martinsried,	 Germany,	 and	 conducted	 by	 the	 first	












d The structure of the autoinhibited human full-length talin1
was analyzed by cryo-EM
d Talin1 reversibly changes between a 15-nm closed and a
!60-nm open conformation
d Rod R9/R12 and FERM domains synchronously shield
membrane and cytoskeleton binding
d F-Actin and vinculin binding to talin is regulated by the
opening of talin
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Structural characterization of talin shows
how autoinhibition regulates interactions
crucial for cell-cell contact and tension
sensing.
Dedden et al., 2019, Cell 179, 120–131





The Architecture of Talin1 Reveals
an Autoinhibition Mechanism
Dirk Dedden,1 Stephanie Schumacher,1 Charlotte F. Kelley,1Martin Zacharias,2 Christian Biertümpfel,1 Reinhard Fässler,3
and Naoko Mizuno1,4,*
1Department of Structural Cell Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany
2Physics Department (T38), Technical University Munich, James-Franck-Str. 1, 85748 Garching, Germany





Focal adhesions (FAs) are proteinmachineries essen-
tial for cell adhesion, migration, and differentiation.
Talin is an integrin-activating and tension-sensing
FA component directly connecting integrins in the
plasmamembranewith the actomyosin cytoskeleton.
To understand how talin function is regulated, we
determined a cryoelectron microscopy (cryo-EM)
structure of full-length talin1 revealing a two-way
mode of autoinhibition. The actin-binding rod do-
mains fold into a 15-nm globular arrangement that is
interlocked by the integrin-binding FERM head. In
turn, the rod domains R9 and R12 shield access of
the FERM domain to integrin and the phospholipid
PIP2 at themembrane. Thismechanism likely ensures
synchronous inhibition of integrin, membrane, and
cytoskeleton binding.We also demonstrate that com-
pacted talin1 reversibly unfolds to an !60-nm string-
like conformation, revealing interaction sites for
vinculin andactin.Ourdataexplain how fast switching
between active and inactive conformations of talin
could regulate FA turnover, a process critical for cell
adhesion and signaling.
INTRODUCTION
Focal adhesions (FAs) are intracellular protein assemblies that
serve as tension-sensing anchoring points to link cells to the
extracellular environment (Geiger et al., 2009; Parsons et al.,
2010). FAs not only tether cells to the extracellular matrix
(ECM), but also facilitate intracellular reorganization, resulting
in dynamic changes in cell functions and cell morphologies (Gei-
ger et al., 2009; Legate et al., 2009; Parsons et al., 2010). FAs
consist of hundreds of proteins in a layered arrangement that
closely regulate each other (Kanchanawong et al., 2010). The
first layer consists of integrin-signaling components at the
plasma membrane, the second of force-transduction compo-
nents, the third of actin-regulatory factors, and the fourth layer
is made up of actin fibers. Several key proteins act to coordinate
the individual functions of each layer, mediate crosstalk between
layers, and to connect these layers with integrin receptor, the
master-controller that links cytoplasmic FA complexes to the
ECM (Bachir et al., 2014).
FA-mediated cellular processes are facilitated by alternating
states of active and inactive integrins. In migrating cells, integrin
activation initiates vast FA formation, allowing cells to attach to
the extracellular environment, whereas integrin inactivation, fol-
lowed by disassembly of FAs, detaches cells. This cycling of
on/off states allows cells to continuously change anchoring
points, facilitating cellular movement. Talin is a key component
in FAs, responsible for activating integrins andmediating both in-
side-out and outside-in signaling (Tadokoro et al., 2003; Harbur-
ger and Calderwood, 2009; Nieswandt et al., 2007). Talin
activates integrin by associating with the cytosolic tail of integrin
beta-subunits. Once engaged, talin can assume an elongated
conformation up to 100 nm in length (Liu et al., 2015), directly
linking the beta-integrin subunit in the first layer of the FA to actin
bundles in the fourth layer (Kanchanawong et al., 2010). By span-
ning all four layers of the FA, talin is in a unique position to act as a
structural scaffold, greatly contributing to the overall composi-
tion and organization of FA complexes (Calderwood et al.,
2013). In addition to its role as an integrin activator, talin also
acts as amechanosensor; it stretches like a spring and transmits
tension between the ECM and the actomyosin machinery within
the FA (Austen et al., 2015; Kumar et al., 2016), a process which
is essential for regulating FA maturation and stability. As such,
the transition between active and inactive talin likely plays a
key regulatory role in FA dynamics, similar to the activation
and inactivation of integrins.
Talin is a large, 270 kDa protein with 18 domains comprising
an!50 kDa globular head, a long rod made of 62 helices forming
13helicalbundle (rod) domains (R1–R13) (Calderwoodetal., 2013;
Goult et al., 2013), and a dimerization (DD) motif at the C terminus
(Gingras et al., 2008). A unique conformational change of talin fa-
cilitates its spring-likebehavior, throughwhich talin canunfold into
a linearly elongated 60–100 nm rod-like shape (Liu et al., 2015;
Molony et al., 1987; Winkler et al., 1997). This allows it to bind to
at least 11 different FA components including vinculin and actin
(Goult et al., 2018). The talin head contains a 4.1-ezrin-radixin-
moesin (FERM) domain with four subdomains (F0–F3), which is
a common structural feature of several integrin tail-binding pro-
teins (Elliott et al., 2010; Garcia-Alvarez et al., 2003; Goult et al.,
2010; Rees et al., 1990). The FERM domain contains the integ-
rin-binding site IBS1 (Tanentzapf and Brown, 2006; Wegener
et al., 2007) and phosphatidylinositol-4,5-bisphosphate (PIP2)
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recognition site, allowing talin to attach to the membrane surface
in a regulated way. The force-mediated stretching of talin is
thought to follow (Atherton et al., 2015;Margadant et al., 2011), re-
sulting in the exposure of up to 11 cryptic binding sites for vinculin
(Fillingham et al., 2005; Gingras et al., 2005; Izard et al., 2004; Pa-
pagrigoriouetal., 2004). Thebindingof vinculin to talin isproposed
to reinforce FA strength, as vinculin facilitates binding to actin, re-
sulting in a cable-like configuration of F-actin (Case et al., 2015;
Kanchanawong et al., 2010; Liu et al., 2015; Carisey et al., 2013;
Humphries et al., 2007) and triggering the maturation of the FA
(Zaidel-Bar et al., 2003).
While the active form of talin is well-characterized, the critical
state of the inhibited form of talin is scarcely understood. The
importance of talin inhibition is highlighted by the fact that disrup-
tion of proper talin inhibition leads tomorphogenetic defects dur-
ing fly development (Ellis et al., 2013) and it hasbeen implicated in
the migration of metastatic cancer cells (Desiniotis and Kypria-
nou, 2011; Fang et al., 2016; Haining et al., 2016). In its autoinhi-
bited state, talin has a compact conformation (Goldmann et al.,
1994; Goult et al., 2013;Winkler et al., 1997), with domains folded
into each other, to occlude the interaction sites for binding part-
ners such as integrin, membrane, vinculin, and F-actin. Although
individual, truncated fragments of talin havebeenwell-character-
ized, the regulation of full-length talin and the interplay among its
domainsare largely unknownonamolecular level. For example, a
truncated fragment of the FERM domain (F3) was shown to
interact with the R9 rod domain (Song et al., 2012); however,
the overall mechanism is unclear because of the lack of informa-
tion about the full-length architecture of talin.
Here, we report a cryoelectron microscopy (cryo-EM) struc-
ture of the autoinhibited form of recombinantly produced full-
length talin1. The structure reveals charge-based interactions
among the 13 rod domains of the talin1 monomer that entangle
the protein into a compact 15 nm globular architecture, which is
further secured by respective interactions between the F2 and
F3 FERM subdomains and the R12 and R9 rod domains. Inter-
estingly, the PIP2-binding surface of the FERM domain is
completely covered by the rod domain R12 to occlude access
to the plasma membrane. The integrin-binding site is located
at the deepest part of the autoinhibition pocket. The closure
of the rod domains impedes binding to vinculin and to actin via
the actin-binding site 2 (ABS2), although it does not occlude
the other actin-binding site, ABS3. By mimicking talin activation,
we facilitated talin1 binding to F-actin and vinculin. On the basis
of these results, we propose a molecular model that explains
how talin activation is controlled at a PIP2-enriched membrane
surface and how the protein transitions from a 15 nm globular
structure to a 100 nm extended structure. Our results have
wide-ranging implications for the mechanistic understanding of
FAs and protein activation.
RESULTS
The Full-Length, Autoinhibited Talin1 Structure Shows
Molecular Closure of the Rod Domains by the FERM
Domain
Talin is thought to adopt open and closed conformational states
(Figure 1A). While open talin is amenable to further stretching by
its interacting partners, the globular state is likely to take on an
autoinhibited conformation that hinders access tomany of talin’s
binding sites, restricting interactions with other FA proteins. The
autoinhibited form is thought to be the cytosolic state of talin that
does not engage in FA assembly. It has been a challenge, how-
ever, to obtain a molecular view of the autoinhibited conforma-
tion. We successfully purified recombinantly expressed talin1
and pursued a full structural and biochemical characterization.
The cryo-EM analysis of full-length talin1 (talin-FL) in the
autoinhibited conformation (Figures 1B, S1, and S2; Table S1)
revealed an intertwined architecture. Although the intrinsic flexi-
bility of talin limited the resolution of the structural reconstruction
to a global resolution of 6.2 Å (Figures S2A–S2C; Table S1), the
clear connectivity of the rod domains within the density map
facilitated robust fitting of available structures of the 13 individual
rod domains and the F2 and F3 subdomains of the FERMdomain
(Figures 1C and S3). We performed further refinement using a
flexible fitting scheme by restraint molecular dynamics (Salo-
mon-Ferrer et al., 2013). Our results show that the rod domains
are entangled with each other, resulting in a compact organiza-
tion, and the FERM domain closes the assembly via two
anchoring points on rod domains R9 and R12, respectively,
acting as a lid to secure the closure of the talin architecture (Fig-
ure 1D). At the first anchoring point, located in the deepest
groove of the autoinhibition pocket (Figure 1E), the interacting
surface between R9 and F3 agrees well with a previously re-
ported crystal structure of isolated F3 and R9 fragments (Song
et al., 2012) (Figure S4), which are necessary for talin inhibition
in cells. At the second anchoring point (Figure 1E), located at
the critical connecting point for the closure of talin1, K272 and
K274 in F2 contact E2288 and D2297 at the C terminus of R12,
respectively (Figure 1D).
While the F2 and F3 FERM subdomains revealed interactions
necessary for talin1 autoinhibition, the densities corresponding
to the F0 and F1 FERM subdomains were not visualized in our
structure (Figure 1E). F0 serves as an interaction surface for
the small GTPase Rap1 (Zhu et al., 2017), which acts as a recruit-
ing factor to promote talin engagement with the plasma mem-
brane (Goult et al., 2010; Plak et al., 2016) (Figure 1F). While
these subdomains are missing from our structure, the corre-
sponding fragments were identified by mass spectrometry (Fig-
ure S3B). This indicates that the F0-F1 subdomains are flexibly
attached to the talin core structure, presumably by a long, 30
amino-acid linker between F1 and F2 (Figure 1E). Hence, F0
and F1 are likely not part of the inhibited structure, which sug-
gests that talin can be recruited to the membrane surface via
Rap1 without requiring disentanglement of the rod domains or
disruption of the FERM domain interaction with R9 and R12 (Fig-
ures 1E and 1F).
The Closed Talin Configuration Occludes the Integrin-
Binding Site and the Membrane-Binding Surface on the
FERM Domain
The talin FERM domain was shown to interact with PIP2 (Chin-
thalapudi et al., 2018; Or1owski et al., 2015; Song et al., 2012).
Specific residues responsible for this interaction were recently
identified including K272 of F2 and K316, K324, E342, and
K343 of F3 (Chinthalapudi et al., 2018). We mapped their
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locations to understand the geometrical relationships among
them in full-length talin (Figure 1D). In the autoinhibited talin
structure, the PIP2-binding surface was mostly covered by the
rod domains, particularly by a region at the C terminus of R12,
ensuring that the binding site was inaccessible to PIP2 (Figures
1D and 1G). This region, containing the negatively charged
amino acids E2288, E2294, and D2297 (Figure 1D), provides
an acidic interface to complement the basic PIP2-binding
surface. Furthermore, to understand the arrangement of
integrin and the plasma membrane with respect to talin in the
open and closed configurations, we superimposed the
available structure of the integrin cytosolic tail in complex with
Figure 1. Structure of Full-Length Talin
(A) Schematic of the domain organization of talin in
the open form (left) and the closed, autoinhibited
form (right).
(B) Three views of the structure of full-length talin.
(C) Molecular fitting of talin fragments (PDB: 3IVF,
1SJ8, 2L7A, 2LQG, 2L7N, 2L10, 5IC1, 2KVP,
3DYJ, and 2JSW) to the EM density map.
(D) The molecular closure of talin achieved by F2-
R12 and F3-R9 interactions and the charged amino
acids surrounding the interaction interface. Bold
highlighted numbers match previously published
PIP2-recognition residues.
(E) Superimposition of the F0-F1 subdomains of
the talin FERMdomain structure (overlaid with grey
shadow, PDB: 3IVF) onto our cryo-EM talin model.
The F0 and F1 subdomains were not visualized in
our structural analysis due to the flexibility of the
F1-F2 linker. The small GTP Rap1-binding site on
F0 is mapped in blue and labelled ‘‘Rap1.’’
(F) The NMR structure of F0-Rap1 (PDB: 6BA6).
(G) Comparison of the F3-R9 and F2-R12 auto-
inhibition sites in the closed structure with the F3-
integrin tail (PDB: 2H7D) and F2-F3-PIP2 (PDB:
6MFS) as well as with the membrane-interaction
sites of the FERM domain (Anthis et al., 2009),
highlighting the mechanism of the autoinhibition of
talin. In the inhibited form R12 forms a ‘‘lid’’
covering the PIP2-binding site on F2-F3.
See also Figures S1, S2, S3, S4, and S5 and
Table S1.
F3 (Anthis et al., 2009; Wegener et al.,
2007) (Figure 1G). The integrin tail was
shown to bind on the surface of the trun-
cated F3 (Song et al., 2012), where R9
also binds in our autoinhibited structure,
showing that the integrin-F3 interaction
and the F3-R9 autoinhibitory interaction
are mutually exclusive. Moreover, the in-
tegrin transmembrane helix directly pre-
cedes the integrin tail, indicating that F2
and R12would have to separate to enable
F2 and F3 to bind the inner face of the
plasma membrane (Figure 1G). We also
noted that the interaction surface of F3
for R9 has been reported to be a key inter-
face for talin-binding partners, such as
RIAM (Yang et al., 2014) and layilin (Wegener et al., 2008), which
are likely involved in talin activation (Figure S4).
The Talin1 Folding Unit Is a Monomer in the
Autoinhibited Form
The last 50 amino acids at the C terminus of talin1 have been
crystalized as a coiled-coil in a dimeric structure (Gingras
et al., 2008) (termed DD domain), suggesting the possibility
that talin is capable of dimer formation. Furthermore, talin has
been separately observed as a dumbbell-shaped dimer (Gold-
mann et al., 1994) when interacting with actin and as entwined
dimers forming a globular assembly (Goult et al., 2013), keeping
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the question open as to whether or not talin dimerization is
necessary for its autoinhibition. Our cryo-EM structure clearly
showed that talin1 monomers are capable of achieving an auto-
inhibited architecture.
The DD domain, which follows R13, was not clearly visible in
our structure because of its flexibility, which in turn indicates
that it is not engaged in the autoinhibited conformation. Indeed,
a truncated talin construct that lacked theDDdomain (talin-DDD)
(Figure S3A) was still capable of assuming the autoinhibited
conformation (Figure 2A), and analysis by size-exclusion
chromatography coupled with multi-angle light scattering
(SEC-MALS; Figure 2B) showed that both talin-FL and talin-
DDD behave as monomers. Therefore, the DD domain appears
to be inactive or not strong enough to hold talin-FL dimers
together when talin is in the autoinhibited state.We further tested
if we could find talin dimers as a minor component in the molec-
ular population. Sucrose-gradient centrifugation of talin-FL in the
presence of a concomitant gradient of the cross-linker glutaral-
dehyde (GraFix) (Stark, 2010) showed a minor population of talin
thatmigrated differently in solution as well as on SDS-PAGE (Fig-
ure 2C), suggesting the presence of a talin-FL dimer, in agree-
ment with the previous report (Goldmann et al., 1994). In
contrast, talin-DDD did not display the corresponding minor
band and showed only a single monomeric population, indi-
cating that DD is the only domain in talin that is capable of facil-
itating dimerization.
Weak Interactions among Rod Domains Maintain the
Compaction of Talin
To explore how the molecular opening of talin is regulated, we
varied the ionic environment and tested if and how the conforma-
Figure 2. The Dimerization Domain Is Not
Necessary for the Closure of Talin
(A) Negative-stain EM image of talin-DDD lacking
the dimerization domain at 75 mM KCl, and 2D
averages of the particles (right), showing a
morphology similar to that of talin-FL.
(B) Size-exclusion chromatography coupled with
multi-angle light-scattering profile of talin-FL and
talin-DDD at 75 mM KCl, showing molecular
weights corresponding to monomers. LS, light
scattering, normalized; UV, absorbance.
(C) Centrifugation profiles of talin-DDD and talin-FL
using the GraFix method. Talin-FL has an extra
band in the fraction at higher sucrose density (open
arrowhead). Black triangles depict the gradient of
sucrose and glutaraldehyde concentrations.
tion was changing. When we raised the
ionic environment to 500 mM salt (NaCl
or KCl), the conformation of full-length
talin changed from the globular, closed
architecture to the open, strand-like
conformation (Figures 3A and 3B) with a
length of 560 Å (SD = 170 Å) (Figure 3C),
which fits well to the reported length of ta-
lin in a cell (Kanchanawong et al., 2010;
Margadant et al., 2011). We looked for ev-
idence of the conformational change as a function of the salt
concentration using dynamic light-scattering (DLS) (Figure 3D),
and the results fit well with a two-state model of protein
folding-unfolding. At an ionic strength of 234 mM salt, the two
states were equally populated and at a physiological salt con-
centration of 150mM, 81% of talin had a compact conformation.
We also found that this conformational change was reversible
across fluctuating salt concentrations (Figure 3E).
Furthermore, we tested the importance of the inter-domain in-
teractions for autoinhibition by creating point mutations as well
as truncated talin constructs lacking the key domains for the
interaction of F2-R12. We created a C-terminal truncation
N-R11 lacking R12 and the C-terminus (Figure S3A), one of the
two contact points necessary for the FERM-rod interactions,
as well as N-R12 (Figure S3A). The DLS experiments showed
the conformational changes of both constructs in response to
the increase of salt concentration (Figure 3F). Point mutants of
talin-FL altering the charge at the key interacting points on R12
(talin-FL-5K: E2288K/E2294K/D2297K/E2299K/D2300K and ta-
lin-FL-2K: E2288K/E2294K, Figure 1D) revealed a compact
conformation at 75 mM salt and underwent a conformational
change similar to wild type talin-FL upon change of the salt con-
centration (Figure 3G). These experiments led us to hypothesize
that the rod domains themselves interact with each other to
maintain a compact formation.
The rod domains contain several binding sites for critical FA
components. Those sites include the F-actin-binding sites
ABS2 and ABS3 onR4-R8 andR13-DD, respectively (Hemmings
et al., 1996). We observed additional contacts among rod do-
mains, as shown by the mapping of neighboring domains (Fig-
ure 4A). Particularly, R4 is placed at the ‘‘core’’ of the globular
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architecture and shielded by several rod domains (Figure 4B).
We therefore tested the overall interactions among the rod do-
mains by using a truncation construct that lacks the FERM
domain (R1-C). DLS showed the change of the conformation in
response to salt concentration (Figure 4C). To visualize the na-
ture of the interaction, we calculated the electrostatic surface
potential of each of the individual rod domains surrounding R4
and estimated the interaction energies of those domains to R4
(Figures 4A and S5). The calculated energy landscape for the
domain-domain interactions indicated that the binding is rather
weak (Figure S5B), resulting in an overall marginal stability. The
rod domains may not rigidly bind to one another without cooper-
ative, multi-module packing, as induced by the overall arrange-
ment of the full-length protein. This explains the observation
Figure 3. Two-State Conformational Ensemble of Talin
(A) Negative-stain EM image of talin-FL in the compact conformation at 75 mM KCl.
(B) Talin-FL in the open conformation in the presence of 500 mM KCl. Green arrowheads indicate examples of open talin.
(C) Distribution of the lengths of the open talin molecules from B (560 ± 170 Å, mean ± SD, N = 89).
(D) Dynamic light-scattering (DLS)measurements of the hydrodynamic radius of talin-FL under various salt concentrations, showing the conformational change of
talin as a function of salt concentration. The fitted curve indicates that talin adopts both conformations at an equal ratio at a salt concentration of 234 mM. At a
physiological salt concentration of 150 mM, 81% of talin employs the compact formation.
(E) Reversible conformational change of talin depending on the salt concentration as determined by DLS. Left: talin employs a closed conformation at an ionic
strength of 75 mM. Center: talin opens and increases its size when the ionic strength is increased to 500 mM. Right: talin closes again when the ionic strength is
lowered back to 75 mM, showing that the shape change of talin is reversible.
(F) DLS measurements of the hydrodynamic radius of N-R11 and N-R12 under various salt concentrations, showing a conformational change comparable to
talin-FL with a lower amplitude. The data point at 250 mM was removed as the measurement was outside of the dynamic range of the detector.
(G) DLS measurements of point mutants of talin-FL-2K and talin-FL-5K, also showing conformational changes dependent on salt concentration. Error bars show
standard deviations.
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that the talin architecture is highly sensitive and how its confor-
mation can rapidly change in response to salt.
The Closed Conformation of Talin Prevents Vinculin
Binding, whereas theOpenConformation Binds Vinculin
with 1:1 Stoichiometry
Vinculin is a major talin-binding partner that facilitates crosstalk
between talin and actin through its talin-binding head domain
(V-head) and its actin-binding tail domain (V-tail) (Borgon
et al., 2004; Johnson and Craig, 1994). Sequence-based anal-
ysis identified 11 potential vinculin-binding sites (VBSs) in talin
(Gingras et al., 2005). Experiments using combinations of talin
rod fragments indicated that R3, containing two VBSs, is a
potent binding site for vinculin. It has been proposed that the
unfolding of the helical bundle in R3 exposes the otherwise hid-
den binding domain to vinculin (Izard et al., 2004; Yao et al.,
2014). Our truncation experiments supported that notion, as
the talin fragments R1–R8 and R1–R3 formed complexes with
V-head, whereas R4–R8 did not (Figure S6). It was unclear,
however, how those observations would be reflected in the
context of full-length talin.
To test the binding of vinculin to talin-FL, we performed
reconstitution assays using size-exclusion chromatography
(SEC, Figure 5A) at 75 mM KCl, where talin shows a compact
architecture. While various truncations of talin including R3
readily bound to vinculin (Figure S6), the majority of talin-FL
did not form complexes with full-length vinculin, V-head, or
the vinculin mutant (V-mut, N773A/E775A) (Cohen et al.,
2005), which exposes the talin interaction site by weakening
the autoinhibition of vinculin (Figure 5A, first row). These findings
suggest that the opening of the R3 helical bundle is hindered by
steric constraints in the autoinhibited form of talin. The root of
R3 is connected to R4, which is buried in the core of autoinhi-
bited talin. Therefore, we attempted to reconstitute the talin-vin-
culin complex with talin at 500 mM KCl, where talin shows an
open conformation. SEC revealed that talin and vinculin formed
stable complexes with the V-mut (Figure 5A, second row). Talin
formed a complex with V-head as well (Figures 5A and 5B).
SEC-MALS showed that the corresponding chromatographic
peaks were monodisperse with a molecular mass of 339 kDa,
corresponding to a complex comprising one talin-FL and one
vinculin molecule (Figure 5C). Interestingly, the talin-FL-2K
and talin-FL-5K mutants, which were designed to weaken the
interactions between F2 and R12 domains, were able to form
a complex with V-head at 75 mM KCl (Figures 5D and 5E) signif-
icantly more than wild type talin-FL. This indicates that the
disruption of F2-R12 leads to a partial access of vinculin, while
these mutants employ compact conformations under this con-
dition (Figure 3G).
The Compact Talin Can Retain Vinculin Head as a
Complex but Induces the Dissociation of Full-Length
Vinculin
To test the conformational change of talin in complex with vincu-
lin, we exposed the reconstituted talin-V-head complex to low
ionic strength conditions. We found that the retention volume
of the SEC peak of the complex shifted from 1.27 mL (500 mM
salt) to 1.31 mL (75 mM salt) (Figures 5A, S7A, and S7E), sug-
gesting a possible compaction of the complex. DLS experiments
of the preformed talin-FL-V-head complex indeed showed a
conformational change upon variation in salt concentration,
similar to talin-FL alone (Figures S7B–S7D). We also observed
the conformational change of the complex of V-head with talin-
FL-2K as well as talin-FL-5K, altogether pointing to the ability
of talin to change its conformation in complex with vinculin
head (Figures S7B and S7C).
The closed talin-V-head complex displayed a globular assem-
bly that was similar to the closed morphology of talin alone (Fig-
ure S7F), although the talin-V-head complex had a slightly larger
size (100 Å 3 230 Å) than talin alone (!100 Å 3 150 Å). Two-
dimensional class averages of the talin-vinculin complex
revealed a 60 Å protrusion from the !100 Å globular head (Fig-
ure S7F, top panel). By combining available crystal structures
of the talin VBS3 peptide bound to the vinculin N-terminal rods
(N-terminal part of the vinculin head) (Izard et al., 2004), a full-
length vinculin (Borgon et al., 2004), and our cryo-EM full-length
talin in the autoinhibited form, we assembled a structural model
of V-head binding to talin at the R3 domain with the talin helical
bundle unfolded (Izard et al., 2004; Yao et al., 2014) (Figure S7G).
This model matched well with the shape of the averaged talin-V-
head complex (Figure S7F), indicating that the 60 Å protrusion on
Figure 4. Interdomain Interactions of Talin
(A) Map of talin interdomain interactions derived from the EM structure.
Binding domains relevant to this study are colored in red (actin-binding site
ABS2), blue (actin-binding site ABS3), and green (vinculin-binding site). Dotted
lines indicate positive (i.e., interactions are not favorable), while solid lines
depict negative interaction energies (i.e., domains are interactive) as deter-
mined by MD simulations (see STAR Methods). The thickness of the lines is
proportional to the calculated energies detailed in Figure S5.
(B) Spatial arrangement of the rod domains surrounding the R4 core in two
vertical slices through the structure.
(C) DLS measurements of the hydrodynamic radius of R1-C under various salt
concentrations in comparison to talin-FL (grey). The size distribution could not
be fit to a two-state model. Error bars show standard deviations.
See also Figure S5.
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the talin-vinculin complex likely corresponds to vinculin binding
to R3. However, when we attempted to re-close talin in complex
with the V-mut including the vinculin tail, vinculin was induced to
be displaced from the complex (Figure S7A). This observation
suggests that the vinculin tail competes with the talin R3 domain
for binding to the vinculin head.
F-Actin Binding Is Enhanced by the Opening of Talin
Another major binding partner of talin is F-actin, which is
located in the fourth layer of the FA. Acting as tension-gener-
ating machinery, actomyosin is thought to ensure the opening
of talin by binding to two sites located at R4–R8 (ABS2) and
R13 (ABS3; Figure 6A). Cell-based experiments with talin rod
mutations suggested that ABS3 plays a role in recruiting talin
to actin at the FA to activate talin, while ABS2 is critical for
the maturation or growth of the FA (Atherton et al., 2015).
Combining our structural findings, we hypothesized that the
opening of talin is correlated with the engagement of talin to
actin and tested the binding of various truncated talin variants
to F-actin by co-sedimentation assays.
Figure 6. Talin-F-Actin Binding Assay
(A) Scheme of actin-binding domains ABS2 and
ABS3 in the context of the autoinhibited talin
structure.
(B) Table summarizing tested constructs for
F-actin binding and vinculin accessibility of talin in
compact conformation (75 mM KCl).
(C) Representative SDS-PAGE analysis of the
F-actin co-sedimentation assay with various talin
constructs at 75 mM salt. The dotted line indicates
the elimination of an irrelevant lane from the gel.
(D) Quantification of the co-sedimented talin frag-
ments. Data are represented as mean ± SD.
N-R12, 0.68 ± 0.08; N-R11, 1.3 ± 0.2; N-R11 +
V-head, 1.1 ± 0.3; R1-C, 1.1 ± 0.2; and R1-C +
V-head, 1.3 ± 0.4. Differences between talin-FL
and N-R12 as well as N-R11 are statistically sig-
nificant (marked with *).
See also Figure S7.
Figure 5. Interaction Assays of Talin-FL and Vinculin under Various Conditions
(A) Talin-FL and vinculin reconstitution assays using size-exclusion chromatography (SEC). An ionic strength of 75 mM was used for the reconstitution assays
shown in the upper panel and 500 mM in the lower panel. SDS-PAGE profiles (talin-vinculin mixture, talin control, vinculin control) of the peaks are shown below
the SEC profiles. In order to achieve complex formation, it is necessary that both talin and vinculin employ open conformations (bottom-center and bottom-right).
V-fl, vinculin full-length; V-mut, vinculin (N773A/E775A) mutant; V-head, vinculin head. Minor shoulders at the left side of talin peaks correspond to degraded talin
without FERM domain. The control runs for talin come from the same experiment and the corresponding profile and SDS-PAGE are shown multiple times for
comparison. The y-scaling has been adjusted for the different amplitudes of the chromatograms.
(B) Negative-stain EM image of vinculin head bound to open talin at 500 mM KCl.
(C) SEC-multi-angle light-scattering profile of V-head bound to open talin with a calculated molecular weight of 339 kDa, indicating that the complex is madewith
1:1 stoichiometry. LS, light scattering, normalized; UV, absorbance.
(D) SEC reconstitution assay of talin-FL-2K mutant and vinculin head at 75 mM salt.
(E) SEC reconstitution assay of talin-FL-5K and vinculin head. The purified proteins have never been exposed to 500mM salt, which facilitates the opening of talin.
The complex formation of these mutants and V-head is observed (indicated by red lines). The control runs for V-head in (D) and (E) come from the same
experiment and the corresponding profile and SDS-PAGE are shown twice for comparison.
See also Figures S6 and S7.
First, the truncated construct N-R12
was tested for binding to F-actin. In the
tested condition at 75 mM KCl, N-R12,
like talin-FL, employed an autoinhibited compact form (Fig-
ure 3F) that did not form a complex with vinculin (Figures 6B
and S7H). Reflecting the fact that N-R12 lacks ABS3, the
binding of F-actin to N-R12 was reduced compared to talin-
FL (Figures 6C and 6D). Next, we tested the C-terminal trunca-
tion construct N-R11, which lacks the R12 domain. Without
R12, talin N-R11 compaction is weak enough for vinculin
to associate (Figures 6B and S7I). In contrast to N-R12,
N-R11 bound F-actin with even higher amounts than talin-FL
(Figures 6C and 6D), despite the fact that it lacks ABS3.
Those results indicate that loosening the autoinhibitory lid
(R12) of talin directly correlates with the activation of the F-actin
binding of ABS2 as well as with vinculin binding. We also tested
the truncation of the N-terminal FERM domain (R1-C) in the
same way. R1-C showed binding similar to that of N-R11,
although the described F-actin-binding activity of ABS1 at the
FERM domain was missing from the fragment. R1-C was also
capable of binding to the vinculin head (Figures 6B and S7J);
however, it displayed no significant enhancement of F-actin
binding.
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DISCUSSION
Mechanism of Talin Regulation
In cellular environments, the concentration of talin can be as high
as 50 mM (Zeiler et al., 2014; Zhu et al., 2017), making talin one of
the most abundant components in cells. The activation of talin
within FAs is essential; however, it is also critical that the adhe-
sion components can be properly switched off to control cell
attachment and migration. Therefore, the autoinhibited state of
talin is essential (Ellis et al., 2013). Information is available about
interactions among individual talin fragments (Goult et al., 2013;
Song et al., 2012); however, the molecular architecture and the
mechanism of talin’s autoinhibition have been unknown in the
regulatory context of full-length talin. We uncovered how talin
can be folded to ensure its autoinhibition. A network of polar in-
teractions keeps the 13 rod domains tangled into a compact
globular architecture with the R4 domain buried in the core,
thus shielding R4 and the actin-binding site ABS2 against actin
binding. The compact architecture was further locked down by
contacts between the F2 and F3 subdomains of the FERM
head and the R12 and R9 rod domains, respectively. The PIP2
binding FERM domain wasmasked by the R12 domain inhibiting
the interaction of talin to the inner leaflet of the plasma mem-
brane. The densities of R11–R13 are not well defined and
show flexibility in the 3D classification (Figure S1C). This sug-
gests that the connection between R12 and FERM domain F2
is loose. The interruption of this interaction may be sufficient to
grant access to binding partners such as vinculin, whose binding
cannot open the molecule completely. The conformational
change of talin can be seen as an ensemble of open and closed
states, which can be reversibly shifted by the change of salt con-
centration in vitro. The open conformation of talin likely mimics
the activated talin stabilized by the actomyosinmachinery during
FA initiation.
Talin-Vinculin Complex Formation during Autoinhibition
We observed that one vinculin-binding site is readily available
when full-length talin is released from the autoinhibited state
without the application of any active force. Intriguingly, talin is
able to reverse back to the closed conformation while vincu-
lin-head is still bound to R3, but only in the absence of the vin-
culin tail. We speculate that this may hint at a mechanism to
release vinculin when talin is inactivated and no longer engaged
in the FA assembly. The closure of talin and concomitant
folding of R3 may weaken the interaction of vinculin head to
R3. In turn, the competition of vinculin tail for the head domain
becomes more effective, resulting in the inactivation of vinculin
and release from the complex in the autoinhibited form. It will
be interesting to structurally map the interaction surface and
find out which of the talin-binding partners can bind to the
autoinhibited form of talin. Such an analysis will shed light on
the functional role of talin in the cytosol and help to determine
if there are preformed complexes that act as precursors of FA-
related complexes. Along the same line, it is possible that talin
dimerization might also occur upon talin activation and elonga-
tion. Binding to actin further expands the footprint of talin and
exposes the C-terminal dimerization domain, as suggested
previously (Goldmann et al., 1994), while dimerization appears
Figure 7. Model of Talin Activation
(1) Our structure of talin in the closed form reveals how inactivation is achieved through occlusion of functional sites. Rap1-mediated recruitment of talin to
membranes can occur without breaking the closed formation of talin as the F0 and F1 subdomains are accessible.
(2) Our structural analysis also indicated that the closed form of talin is in equilibrium with a semi-opened state due to the instable FERM-lid connection
(see Figure S1).
(3) Upon binding to the PIP2-embedded membrane surface, the R12-F2 and R9-F3 interfaces are broken because of competitive interactions with PIP2 and
integrin, respectively (shown in Figure 1). The binding to the integrin tail hinders the F3-rod interaction (Wegener et al., 2007) and releases the rod domains from
the FERM head as well as from the plasma membrane.
(4) The further opening of the rod domainsmay require themechanical aid of actomyosin pulling via the ABS3 and ABS2 actin-binding sites. Vinculinmay also take
an active role in reinforcing the binding of talin to actin (Humphries et al., 2007).
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dispensable when talin is autoinhibited. Talin dimerization of-
fers an additional layer of regulation and the possibility for
larger complexes to be assembled from preformed FA sub-
complexes. Further structural analysis of full-length talin in its
active, elongated form in comparison with its autoinhibited
form will provide a comprehensive view of talin function during
FA initiation and maturation.
The Topological Positioning of Talin Is a Key Step in FA
Activation
Our talin structure showed that the globular rod domains
occlude the membrane-binding plane of the FERM domain. On
the other hand, the N-terminal FERM F0-F1 subdomains and
the C-terminal DD domain were not involved in maintaining the
structural organization of the autoinhibited form of talin, indi-
cating that those domains are freely accessible and not inhibited
when talin is closed. In particular, F0 has been shown to be a key
binding domain for Rap1, which has been suggested as the first
step in the recruitment of talin to the cell-membrane surface (Zhu
et al., 2017).
In addition, talin has a 30 amino-acid flexible linker between
the F1 and F2 subdomains that separates F0-F1 from the glob-
ular autoinhibited structure (F2-DD). This separation may allow
F0-F1 to ‘‘search’’ for cofactors. Our findings, together with
previous results, suggest a model of how talin is recruited
and correctly positioned at the membrane surface (Figure 7,
model). Autoinhibited talin is recruited to the membrane via
its freely accessible F0 subdomain in a Rap1-assisted manner.
Thus, the FERM domain orchestrates the binding of Rap1 on
the one hand (Zhu et al., 2017), while on the other it accesses
the exposed, negatively charged plasma membrane via the
flexible loop inserted in the F1 subdomain (Goult et al., 2010).
This recruitment process increases the local concentration of
PIP2, due to the recruitment of PIPK1g90 by the F3 subdomain
(Di Paolo et al., 2002; Ling et al., 2002). PIP2 may bind to talin,
opening the R12 lid, thus shifting the conformational ensemble
toward open structures. The F3-R9 interaction may then be
abrogated (Figure 7, step 3), allowing the integrin tail to interact
with F3.
This rearrangement releases the rod domains from the head
domain (Figure 7, step 3), activating the interaction sites for
various talin-binding proteins. The rod domains themselves
can be readily approached by vinculin and actin (as shown in Fig-
ure 6), which could lead to the initiation of FA formation (Figure 7,
step 4). Our actin co-sedimentation assays with truncated talin
revealed that ABS2 is inhibited while talin is closed. This shows
that the initial pulling of talin ABS3 by the actomyosin machinery
aids the opening of talin to enable the accessibility of ABS2 as
well as vinculin, as also shown in a previous report (Atherton
et al., 2015). Finally, actin binding would enable actin retrograde
force to exert tensile force on talin, enabling mechanical force to
further stabilize talin opening (Sun et al., 2019). Our structure
provides a mechanistic basis to understand the inhibition and
activation of talin. Although our model is coherent, further testing
is needed to validate key events. Furthermore, other yet-un-
known activating factors may be involved to tightly regulate the
inhibition and activation of talin or to modulate individual func-
tions of talin.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and Virus Strains
Escherichia coli, BL21-Gold (DE3) Agilent Cat# 230132
Escherichia coli, XL1-Blue Agilent Cat# 200249




Potassium Chloride Roth Cat# 6781.1
Sodium Chloride Merck Cat# 1.06404
Ethylenediaminetetraacetic acid (EDTA) VWR Cat# 1.08418.0250
Dithiothreitol (DTT) AppliChem Cat# A1101
2-Mercaptoethanol AppliChem Cat# 4338.0100
D(+)-Saccharose Roth Cat# 4621.1
Glutharaldehyde Sigma Cat# 340855
Octyl b-D-glucopyranoside Sigma Cat# O8001-500MG
Uranyl acetate 2% Science Services Cat# E22400-2
Tris(hydroxymethyl)aminomethane (Tris/Trizma Base) Sigma Cat# T1503
4-Morpholineethanesulfonic acid (MES) Sigma Cat# M8250-250G
Imidazol Merck Cat# 1.04716.1000
Actin (rabbit skeletal muscle alpha actin) Hypermol Cat# 8101-03
L-Glutathione (reduced) VWR Cat# 0399-50G
Glyercol 99.5% Roth Cat# 3783.1
cOmplete EDTA-free, 3 x 20 Tablets Roche Cat# 5056489001
Magnesium chloride Roth Cat# 2189.2
Calcium chloride Roth Cat# 5239.2
Adenosine 5’-triphosphate disodium salt hydrate Sigma Cat# A2383-10G
Protein Marker VI (10 - 245) pre-stained AppliChem Cat# A8889.0500
Critical Commercial Assays
NucleoSpin Plasmid EasyPure Macherey Nagel Cat# 740727.250
Roche cOmplete His-Tag purification column Roche Diagnostics Cat# 06781535001
HiTrap Q HP column GE Healthcare Cat# 17-1154-01
16/600 Superdex 200 GL GE Healthcare Cat# 28-9893-35
3.2/300 Superdex 200 increase GE Healthcare Cat# 28-9909-46
3.2/300 Superose 6 increase GE Healthcare Cat# 29-0915-98
GSTrap FF, HiTrap GSH/GST GE Healthcare Cat# 17-5131-01
Deposited Data
Cryo-EM map of talin-FL This study EMD-4772
Atomic model of talin-FL This study PDB 6R9T
Experimental Models: Organisms/Strains
Escherichia coli, BL21-Gold (DE3) Agilent Cat# 230132
Escherichia coli, XL1-Blue Agilent Cat# 200249
Oligonucleotides
DNA Primers, see Table S2 This study N/A
Recombinant DNA
Plasmid DNAs, see Table S2 This study N/A
(Continued on next page)
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Naoko
Mizuno (mizuno@biochem.mpg.de). Materials and plasmids generated in this study (see Table S2) are available upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
E. coli XL1-blue was cultured at 37!C in LB medium supplemented with 100 mg/ml ampicillin for plasmid DNA extraction. E. coli
BL21(DE3) gold was cultured at 37!C in ZY auto-induction medium supplemented with 100 mg/ml ampicillin until reaching an
OD600 >2. The temperature was then switched to 16!C for protein expression overnight. Plasmids used for protein production are
listed in Table S2.
METHOD DETAILS
Protein purification
Expression constructs of full-length talin1 (talin-FL) were prepared using human talin1 DNA (a gift from Christophe Le Clainche). DNA
of talin-FL was amplified using PCR and subcloned into a pCB homemade expression vector with a His tag at the C-terminus for
bacterial or mammalian cells. Talin1 was expressed in E. coli BL21 (DE3) gold using ZY auto-induction medium. Cells were lysed
by sonication in 50 mM Tris-HCl pH 7.8, 500 mM NaCl, 10 mM imidazole, 1 mM DTT, 5 mM EDTA, purified by nickel-affinity chro-
matography (complete His-Tag purification column, Roche) and anion exchange (HiTrap Q HP, GE Healthcare). The His-tag was
removed using 3C protease and proteins were further purified by size-exclusion chromatography using a Superdex 200 16/600 col-
umn (GE Healthcare) in 20 mM HEPES pH 7.8, 75 mM KCl, 0.5 mM b-Mercaptoethanol and 0.5 mM EDTA and 10% glycerol.
Talin truncation and mutation variants were obtained using mouse talin FL (pLPCXmod-Talin1-Ypet; a gift from Carsten Grashoff)
as a template and cloned into homemade expression vectors (pCB and pEC vectors). Mouse talin constructs used in this study were
1-2482 (talin -DDD), 482-2541 (R1-C) 1-2294 (N-R12), 1-2141 (N-R11), 482-1655 (R1-R8), 482-913 (R1-R3), 913-1655 (R4-R8), talin
mutant E2288K/E2294K/D2297K/E2299K/D2300K (talin-FL-5K) as well as talin mutant E2288K/E2294K (talin-FL-2K) (see Table S2).
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Software and Algorithms
Serial EM Mastronarde, 2005 http://bio3d.colorado.edu/SerialEM
Gctf Zhang, 2016 https://en.wikibooks.org/w/index.php?
title=Software_Tools_For_Molecular_
Microscopy&stable=0#Gctf
Gautomatch Andrew Carter lab,
unpublished
https://www.mrc-lmb.cam.ac.uk/kzhang/
MotionCor2 Zheng et al., 2017 https://msg.ucsf.edu/software
RELION Zivanov et al., 2018 http://www3.mrc-lmb.cam.ac.uk/relion
cryoSPARC Punjani et al., 2017 https://cryosparc.com/
UCSF Chimera Pettersen et al., 2004 http://www.cgl.ucsf.edu/chimera/
Bsoft Heymann and Belnap, 2007 https://lsbr.niams.nih.gov/bsoft/
Coot Emsley et al., 2010 http://www2.mrc-lmb.cam.ac.uk/Personal/
pemsley/coot/
PHENIX Afonine et al. 2018 https://www.phenix-online.org/






MaxQuant Cox and Mann, 2008 https://www.maxquant.org/maxquant/
Other
Carbon-coated copper grids Home-made N/A
Quantifoil Cu 200 mesh R1.2/1.3 grids QUANTIFOIL N/A
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The DNA fragments were amplified using PCR and subcloned into a pCB vector containing a cleavable N-terminal Venus-His8-Sumo
tag or His tag. Proteins were expressed in E. coliBL21 (DE3) gold in ZY auto-inductionmedium. Talin truncation variants were purified
using the same procedure as talin-FL. Tags were removed using 3C or Senp2 protease and proteins were further purified by size-
exclusion chromatography using a Superdex 200 16/600 column (GE Healthcare) with 20 mM HEPES pH 7.5, 75 mM NaCl,
0.5 mM EDTA and 0.5 mM b-Mercaptoethanol.
Vinculin constructs were designed based on a previous report (Cohen et al., 2005) and cloned into homemade pEC vectors con-
taining N-terminal GST-His tag and a 3C-cleavage site. V-head contains a.a. 1-851. Proteins were purified using His-affinity purifi-
cation methods and eluted with 500mM imidazole. Protein fragments were cleaved with 3C protease and dialyzed over night against
20 mM HEPES at pH 7.8, 100 mM KCl, 0.5 mM b-Mercaptoethanol, concentrated and subsequently applied to size-exclusion
chromatography (Superdex 200 16/600, GE Healthcare). All purified proteins were stored at !80"C. Analytical size-exclusion
chromatography experiments using talin were performed in 20 mM HEPES at pH 7.8, 0.5 mM b-Mercaptoethanol, 0.5 mM EDTA
either with 75 or 500 mM KCl to test the influence of salt on the conformational change observed under negative-stain EM.
Gradient Fixation (GraFix) of talin samples
To stabilize weak protein-protein interactions, the GraFix crosslinking protocol was used (Stark, 2010). Talin samples were subjected
to a sucrose and glutaraldehyde gradient of 10-30% and 0-0.2%, respectively, in a buffer containing 20 mM HEPES (pH 7.5),
75 mM KCl, 0.5 mM b-Mercaptoethanol and 0.5 mM EDTA. Gradients were prepared in 2.2 ml ultracentrifuge tubes (open-top poly-
clear tubes, Seton) using a Gradient Station machine (model ip, Biocomp). 50 ml of talin samples at a concentration of 5 mg/ml
(approximately 18.5 mM) were placed on top of the gradients and centrifuged in a TLS55 rotor (Beckman Coulter) at 50 000 rpm,
for 6 h at 4"C, using an OptimaMax-XP ultracentrifuge (Beckman Coulter). 100 ml-Fractions were collected manually from top to bot-
tom and quenchedwith 100mMTris (pH 7.5). Fractions containing themonomeric or dimeric talin, as determined by SDS-PAGEwere
pooled, concentrated, and buffer-exchanged to 20 mM HEPES (pH 7.5), 75 mM KCl, 0.5 mM b-Mercaptoethanol and 0.5 mM EDTA
to remove excess sucrose using Amicon Ultra centrifugal filters (0.5 ml, 50 MWCO).
Mass spectrometry
For validating the full-length coverage of the protein sequence, the talin-FL sample was subjected to peptide mass fingerprinting
analysis. The sample was diluted in equal volume of buffer containing 2% sodium deoxycholate (SDC), 20 mM TCEP and 80 mM
chloroacetamide in 25 mM Tris at pH 8.5 and incubated at 37"C for 20 min. The sample was then further diluted with LC-MS grade
water to reduce the SDC concentration to less than 0.5% and directly digestedwith 1 mg of trypsin (Promega) overnight. The peptides
were then acidified and purified via SDB-SCXStageTips and analysed in aQExactive HFmass spectrometer using a 75min gradient.
Raw data were processed using the MaxQuant platform and all identifications were filtered at 1% false discovery rate (FDR).
Negative-stain electron microscopy
For negative-stain EM, homemade carbon-coated grids were prepared and glow discharged before use. 5 ml of sample was applied
and incubated for 1 min, blotted, washed twice in two drops of water and stained in 2% uranyl acetate for 1 min. The prepared spec-
imens were visualized with a FEI CM200 with an operating voltage of 160 kV equipped with an Eagle CCD camera with a pixel size of
2.16 Å/pix or with a FEI Tecnai F20 at 200 kVwith an Eagle CCD camerawith a pixel size of 2.21 Å/pix. For 2D classifications, particles
were manually or automatically picked using RELION (Zivanov et al., 2018) and extracted in 276 Å boxes. For shape assessment,
1102 (talin-DDD) and 5678 (talin-FL V-head complex, treated with GraFix method for stabilization) particles were selected for refer-
ence-free 2D classification using RELION, resulting in 2D class averages. The lengths of open talin were measured using bshow in
BSOFT (Heymann andBelnap, 2007). Five images of negatively stained talin were filtered usingmedian filter (n=6) aswell as Gaussian
filter (sigma=4) to enhance the contrast of the protein densities. Particles showing clear boundaries were manually selected and their
contour length was measured using the ‘filament’ option in BSOFT, facilitating the tracing of elongated, string-like particles. The his-
togram was created from a population size of N = 89, and the distribution was fit to normal distribution (average 560 Å, S.D. 170 Å).
Cryo-EM analysis of full-length talin
Samples for cryo-EM were applied to glow-discharged R1.2/1.3 Cu 200 mesh holey carbon grids at a concentration of 0.3 mg/mL in
20 mM HEPES at pH 7.8, 75 mM KCl, 0.5 mM b-Mercaptoethanol, 0.5 mM EDTA to ensure the compact formation of talin based on
the DLS experiment shown in Figure 3D. Under salt concentrations of 200 mM KCl and higher, the compact formation of talin mole-
cule was compromised in the cryo-EM environment, yielding poor 2D averages (Figure S2D). The grids were blotted at#95% humid-
ity at 4"C for 4 s and plunged into liquid ethane-propane using a Vitrobot Mark IV (FEI). 11007 micrographs were collected on a Titan
Krios (FEI) at 300 kV equipped with a K2 Summit direct electron detector and a quantum energy filter (20 e-V)(Gatan). Micrographs
were exposed for 10 s at 7.68 e-/Å2/s (total dose 76.8 e-/Å2) and 40 frames were collected in counting mode (pixel size 1.06 Å/pixel).
Defocus was varied between -1 and -3 mm in steps of 0.3 mm. Movies were aligned, gain-normalized and dose-weighted using
MotionCor2 (Zheng et al., 2017). Defocus values were determined using GCTF (Zhang, 2016). Particles were automatically picked
with Gautomatch using the template-free mode (Gaussian blob with 220 Å diameter), imported to RELION-3 (Zivanov et al., 2018)
and extracted in 224 pixel-sized boxes. Extracted particles were applied to 2D classification routine in RELION-3 to remove
contaminations. 1,873,975 particles were selected and after removing low quality classes, initial 3D reconstruction was performed
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using cryoSPARC (Punjani et al., 2017). Using the initial model, 5 batches of 3D classification were performed, yielding several
models of a closed talin structure with different completeness of densities. Particles of the most complete model were combined,
further aligned and classified. 30,438 particles were selected for the final 3D refinement, yielding a final map with a global resolution
of 6.2 Å with up to 5.5 Å resolution in the core of talin using the RELION post-processing routine, using the gold-standard Fourier shell
correction (FCS) = 0.143 criterion. In the final map, the R3 domain was only partially resolved. To visualize the R3 domain, flexible
densities were computationally subtracted from individual particles using available scheme from RELION-3, and as previously
described (Bai et al., 2015), facilitating the focused 3D classification of the core density R1-R10. The particle information and the
alignment parameters of the 3D class with the most prominent density of R3 were applied to the original particles that contain the
flexible densities (FERM domain and R11-C) and the final map with the R3 domain was obtained. This map was used for the assign-
ment of the R3 domain. Finally, to assess the flexibility of the autoinhibition area in the talin structure, 3D classification was performed
to the 750,432 particles obtained from the initial stage of the 3D classification. It was observed that the parts corresponding to R11-
R13 exhibited a weaker density compared to the core part (R1-R10) of the structure, detecting high levels of flexibility. Overall, the
analysis indicated that the packing of talin-FL is sensitive to its environment, which agrees well with its conformational change
observed in our biochemical analysis as well as its cellular function. The graphical summary is depicted in Figure S1.
Molecular dynamics for flexible fitting
For each of the rod fragments (R1-R13) and the FERM domains, crystal and NMR structures are available. The corresponding PDB
entries are 3ivf (FERM domain), 1sj8 (rod domains R1 and R2), 2l7a (R3), 2lqg (R4), 2l10 (R6), 2l7n (R5) 5ic1 (R7, R8, R9), 2kvp (R10),
3dyj (R11, R12), 2jsw (R13). Initially, the structures containing multiple domains (PDB: 3ivf, 1sj8 and 5ic1) were computationally
divided into individual domains. These individual domain structures served as building blocks to build a model of the entire autoin-
hibited structure of talin (Figure S3).
The R1 rod domain has an asymmetric shape and only one unique well-fitted placement and orientation of this structure in the
density could be identified by rigid-body fitting. The C-terminus of the fitted R1model reaches into a neighboring helical bundle den-
sity in the cryo-EM map, which fitted well with the R2 model. The available structure of R1-R2 complex (PDB: 1SJ8) was indepen-
dently fitted using the colores program of the Situs package (Chacón and Wriggers, 2002) showing that they matched to each other.
This fitting served as a first anchor segment. The resolution of the density was sufficient to clearly distinguish between 4-helix and 5-
helix bundle segments in the density. R7 and R8 were readily identified due to the inter-winded helical bundle feature of R7 within R8.
Together with the constraint on the maximum linker length to covalently connect consecutive rod-domains it was possible to define
placements and also orientations of the subsequent rod domains (R3-R13) in order to fit to the density and at the same time, to allow
covalent connection to the previous and subsequent rod-domains. Placements that sterically did not allow connection of consecu-
tive fragments to form a fully connected talin chain were eliminated. Finally, remaining densities, which did not represent a helical
bundle arrangement, were assessed. These remaining densities consisted of two globular entities that were identified as F2 and
F3 domains due to their secondary structures features. Overall, the fitting was performed independent of any available structural
models showing the inter-domain connections. However, our placements brought the F3 segment in close binding vicinity to the
R9 rod-domain. The placement coincided with the crystal structure of F2-F3 in complex with R9 (PDB 4f7g) (within a root-mean
square deviation (RMSD) < 0.8 Å).
The resolution of the cyro-EM reconstruction of 6.2 Å together with the sterical constraints to covalently connect domains with
smaller linker segments readily allowed the identification of the unique topology for the full chain. However, no cryo-EM densities
for the FERMF0 and F1 domains and the DD domain were identified and these parts were not included duringmodel building. Finally,
a full covalently connected chain was formed by connecting N- and C-termini of consecutive rod fragments using the Leapmodule of
the Amber16 package (Salomon-Ferrer et al., 2013) in combination with the ff14SB force field (Maier et al., 2015). The disordered
connection between FERM F3 and R1 was not included and the F2 and F3 domains were treated as separate proteins not covalently
connected to the rod fragments.
The emap/sander module of the Amber16 packagewas used to perform a flexible fitting and sterical force field optimization (based
on the ff14SB force field). In order to keep the structure of each individual template structure (R1-R13 and F2 and F3) close to the
corresponding experimental crystal structure distance restraints between backbone atoms within each fragment were included.
These restraints kept the secondary structure and the arrangement of secondary structures in each domain to within RMSD < 1 Å
from the corresponding experimental domain reference structures. Connecting loops and side chains were nevertheless fully mobile
during flexible fitting. The full start structure was first energy minimized (5000 steps) followed by a Molecular Dynamics (MD) simu-
lation at 300 K (0.5 ns) until no further shift of themean structure was observed followed by another round of energyminimization. The
model was then subjected to manual building and correction in COOT (Emsley et al., 2010) and real-space refinement in PHENIX
(Afonine et al., 2018). The final structure fitted well to the cryo-EM density with a correlation coefficient around the model (CCmask)
of 0.81 without outliers in the Ramachandran plot (Table S1).
Estimation of interaction energies
The interaction energy between selected pairs of talin fragments (enthalpy) was calculated using theMMPBSA (Molecular Mechanics
Poisson Boltzmann Surface Area) approach as implemented in the Amber18 package (Onufriev et al., 2000; Salomon-Ferrer et al.,
2013). Pairs of talin subdomains were extracted from the compact talin autoinhibited structure in the same arrangement as observed
Cell 179, 120–131.e1–e5, September 19, 2019 e4
	 118	
in the full structure. For each case an ensemble of 250 conformations was generated using short MD simulation (0.1 ns, 300 K) keep-
ing the backbone strongly restraint to the starting placement (allowing shifts < 0.1 Å). The mean domain-domain interaction energy
was calculated using the MMPBSA method. It accounts for changes in electrostatic Coulomb interactions, changes in electrostatic
solvation (reaction field with the aqueous environment), changes in mean van-der-Waals interactions and nonpolar (hydrophobic)
contributions that depend on the buried surface area upon complex formation. In theMMPBSA approach, the change in electrostatic
reaction field contributions is calculated by solving the finite-difference Poisson-Boltzmann equation for each structure. The energy
of interaction was estimated by subtracting the contributions of each partner from the result of the domain-domain complex for each
case. Calculations were performed at a monovalent salt concentration of 0.15 M. We note that the calculated interaction energies
represent enthalpic contributions and do not include the entropic penalties of restricting the large ensemble of open and flexible con-
formations of talin to a small ensemble of compact conformations seen in the autoinhibited state.
F-Actin co-sedimentation assay
Actin was purchased fromHypermol, Germany. Actin was polymerized in 10mMTris pH 7.5, 50mMKCl, 2mMMgCl2, 0.2mMCaCl2,
0.2 mM ATP, 0.5 mM DTT for 20 min at RT. Buffer exchange of the samples was performed using Zeba Spin desalting columns
(Thermo Scientific). The buffer for all constructs was 20 mM Tris pH 7.5, 75 mM KCl. 2.5 mM talin fragments were incubated with
2.5 mM F-actin for 15 min at RT. The mixture was then ultra-centrifuged at 175 000 x g (TL-100 Ultracentrifuge, Beckmann) for 20 mi-
nutes at RT. Pellets were re-suspended to comparable volumes as supernatants with 1x SDS buffer. 6x SDS buffer was added to the
supernatant and 10 ml of samples were run on SDS-page and quantified using FIJI (Schindelin et al., 2012).
Analytical size-exclusion chromatography
For analytical size-exclusion chromatography, the buffer exchange of the sample was performed using Zeba Spin desalting columns
(Thermo Scientific) to 20 mMHEPES pH 7.5, 75 or 500 mMKCl, and 10 mMof samples were injected to either an analytical Superdex
200i 3.2/300 (for the reconstitutions of R1-C, R1-R3, R4-R8 and R4-R8 and V-head) or Superose 6i 3.2/300 (all other constructs)
on an ÄKTAmicro system (GE Healthcare). Fractions were collected, mixed with 6x SDS sample buffer and 10 ml were run on
SDS-PAGE.
Dynamic Light-Scattering (DLS)
Formeasurements of hydrodynamic radius changes, talin-FL, talin N-R11 and talin N-R12were initially prepared in 20mMHEPESpH
7.5, 75 mM KCl, 0.5 mM EDTA, 0.5 mM b-Mercaptoethanol. Further, the samples were diluted to a final concentration of 0.3 mg/ml
and final KCl concentrations of 75 – 500 mM (75/100/125/150/175/200/225/250/300/350/400/450/500 mMKCl) in the same buffer in
30 ml wells in a 384-well plate. DLS measurements were performed with a Dynapro Platereader-II Dynamic Light Scattering instru-
ment (Wyatt Technology Corporation) at 20!C. Samples were independently prepared in triplicates and 20 measurement points per
well were taken. The data was analyzed in Dynamic 7.8.1.3 (Wyatt Technology Corporation) and plotted with PRISM (GraphPad). The
fitting of the curve was performed using a nonlinear regression fit with a sigmoidal curve.
Size-Exclusion Chromatography Coupled with Multi-Angle Light-Scattering (SEC-MALS)
To test the molecular weight of the protein complexes, talin-FL and talin truncations as well as the mixtures of talin and vinculin
(1:1 ratio) were prepared in buffer containing 20 mM HEPES, pH 7.5, 75 or 500 mM KCl, 0.5 mM EDTA at 3 mg/ml concentration
and 20 ml were run on a Superdex 200 5/150 GL column on an ÄKTAmicro system (GE Healthcare) coupled to a Viscotek TDA302
detector (Malvern, Herrenberg, Germany) in the same buffer. Bovine serum albumin was used as a standard and the refractive index
increment (dn/dc) was set to 0.180 ml/g for calculations. Data was analyzed using the OmniSEC 4.5 software (Malvern) and plotted
with PRISM (GraphPad).
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification and statistical analysis related to EM data are integral parts of algorithms and software used.
For DLS analysis, the experiments were performed 3 times independently. The results were averaged and the error bars represent
the standard deviations. For the fitting, nonlinear regression fit, sigmoidal curve fitting was applied using the software PRISM
(GraphPad).
For F-actin analysis shown in Figure 6, the experiments were performed at least 3 times independently. The talin-FL band was run
on the same SDS-PAGE gel as an internal control to standardize the variability of the contrast caused by staining conditions of each
SDS-PAGE gels. Therefore, relative quantified values compared to the talin-FL band were used for the analysis. These values were
averaged and standard deviations were obtained. Unpaired t-test was used to assess statistical significance.
DATA AND CODE AVAILABILITY
The cryo-EM map of human talin1 was deposited in the EMDB database with accession code EMD-4772. The flexibly fitted atomic
model was deposited in the PDB with accession code 6R9T.
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Supplemental Figures
Figure S1. Summary of Cryo-EM Data Processing, Related to Figure 1
Top: Representative cryo-EM image of talin-FL at 75 mM salt with representative 2D averages. Bottom: Graphical scheme of image processing. 1.9 million
particles were selected out of 2D classifications. Further 3D classifications and refinement facilitated the final map generation (A – left). To visualize the R3
domain, the core density (R1-R10) was computationally extracted and focused 3D classification of the core density was performed. At the final step of the
processing, the alignment parameters were applied to the original particles to visualize the full density (B – center). Yellow density fitted with an available structural
model of R3. To assess the flexibility of the autoinhibition pocket consisting of the interface between FERM domain F2-F3 and R12-R13 (lid), extensive 3D
classifications were performed, yielding a visualization of the flexible densities of R11-R13 (C – right).
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Figure S2. Quality Control of Cryo-EM Data Processing, Related to Figure 1
A: Local resolution map of the talin-FL structure, showing a resolution range between 5.5 Å and 7.9 Å. B: The Fourier shell correlation (FSC) curve of the talin-FL
structure showing a global resolution of 6.2 Å. The additional line indicates a FSC of 0.143 C: Angular distributions of the particle orientations that were incor-
porated into the final 3D reconstruction. D: Cryo-EM images of talin-FL in the presence of 200mMKCl and 500mMKCl, showing aggregations presumably due to
the talin opening at 500 mM KCl. 2D classifications of talin-FL at 200 mM KCl reveal less robust averages indicating higher structural heterogeneity.
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Figure S3. Talin Fragments Used in This Study and Sequencing Information of Talin-FL, Related to Figure 1
A: Scheme of talin fragments used in this study (top) and the structures (PDB codes) that were used as building blocks for the fitting andmolecular modelling. For
PDBs 3IVF, 1SJ8, 5IC1 and 3DYJ, individual domains are computationally extracted and used independently (see also STAR methods). 2K denotes charge-
reversal double mutation E2288K, E2294K and 5K denotes mutations E2288K, E2294K, D2297K, E2299K, D2300K). B: Peptide detection of talin-FL by mass
spectrometry. The entire sequence of talin (1-2541) is covered, showing no indication of spontaneous cleavage.
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Figure S4. Talin F3-Rod Binding Surfaces Obtained from Our Cryo-EM Map in Comparison to Available Structures, Related to Figure 1
Top-left: Our cryo-EM model of the F3-rod binding surface. Bottom-left: crystal structure (PDB: 4F7G) of truncated F2-F3 and R9. Right: Examples of structures
that bind to the talin F3-rod binding surface. From top to bottom: PDB: 4F7G superimposed to 2H7E (Integrin tail), 2MWN (RIAM), and 2K00 (Layilin).
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Figure S5. Talin Inter-Domain Interactions, Related to Figures 1 and 4
A: Electrostatic surface potential of individual rod domains surrounding R4 and forming the autoinhibition core. Sites contacting each other are indicated with
yellow circles. B: Interaction energies calculated by restraint molecular dynamics simulations for major interaction surfaces in the presence of 150 mM salt.
Units: kCal/mol. We note that the calculated interaction energies represent enthalpic contributions and do not include the entropic penalties of restricting the large
ensemble of open and flexible conformations of talin to a small ensemble of compact conformations seen in the autoinhibited state.
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Figure S6. SEC Reconstitution Assay of Various Talin Rod Domains and the Vinculin Head (V-Head) at 75 mM Salt, Related to Figure 5
The SDS-PAGE analysis corresponds to the profile of the protein mixtures (top), talin control constructs (center), and vinculin head control (bottom), respectively.
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Figure S7. Conformational Change of Talin in Complex with V-Head, Related to Figures 5 and 6
A: Size-exclusion chromatography (SEC) profile of talin and vinculin constructs. Reconstitution assays of talin (open conformation) and V-head as well as V-mut
were performed at 500mM salt, and then the complexwas assessed by changing the salt concentration to 75mM. V-head stays in complexwith talin (blue), while
V-mut dissociates from talin (red). B-D: DLSmeasurements of the hydrodynamic radius of the reconstituted talin constructs (talin-FL, talin-FL-2K and talin-FL-5K)
in complex with V-head under various salt concentrations. In comparison to talin-FL constructs alone (shown in grey), the increased size of the sample is observed
showing complex formation. A conformational change of talin-V-head complex upon the change of salt concentration is also observed. For the case of talin-FL-
5K in complex with V-head, the profile did not fit to a two-state model. E: SEC-multi-angle light-scattering profile of the talin (75mM salt, closed) -V-head complex
showed a molecular weight of 362 kDa, indicating a 1:1 stoichiometry. LS: light scattering, normalized, UV: absorbance F: Negative-stain EM image of the talin-
vinculin head complex in closed talin and two-dimensional averages (right), showing a long protrusion from the main globular density. G: Molecular modeling of
our talin structure (white) with R3 unfolded (yellow) to accommodate the vinculin head density (green). The model was created by combining our cryo-EM talin-FL
(legend continued on next page)
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structure (white) with available structures of a part of the V-head (a.a. 1–258) complexed with talin peptide (a.a. 1944–1969) (PDB: 1RKC, yellow) and the vinculin
head (a.a. 259–843) extracted from full-length vinculin (PDB: 1TR2, green). H-J: SEC profiles of various talin truncation constructs with V-head at 75 mM salt,
showing that the complex formation of talin and V-head occurs only with N-R11 (I) and R1-C (J). N-R12 containing the R12 (lid) did not form a complex with V-head
(H). In the reconstitution assay of R1-C + V-head, a Superdex S200 column was used while a Superose 6 was used for the other assays. The control runs for V-







Despite	 its	 importance	 for	 cellular	 and	 tissue	 function,	 how	 integrin	 a5b1	
functions	and	binds	its	ligand	FN	on	a	molecular	level	has	not	been	fully	understood	so	
far.		
Our	 study	 revealed	 molecular	 insights	 into	 the	 integrin	 a5b1-FN	 interaction,	
which	showed	that	the	interface	is	comprised	of	several	modules.	For	the	first	time,	next	
to	binding	of	the	well-known	RGD	motif,	the	interaction	between	the	synergy	site	on	FN	





was	 also	 observed	 in	 presence	 of	 ligand-mimetic	Mn2+	 and	 only	 changed	 to	 the	 open	
conformation	when	 the	 full	 FN	 ligand	was	 additionally	 present.	 Together,	 the	 results	
obtained	in	our	study	show	that	the	activation	mode	of	integrin	a5b1	differs	from	other	
isoforms	of	the	integrin	family.	
Integrin	a5b1	 is	 the	 major	 FN	 receptor	 in	 the	 human	 body.	 It	 is	 ubiquitously	
expressed	 and	 has	 been	 shown	 to	 play	 a	 direct	 role	 in	 angiogenesis	 (Schaffner	 et	 al.,	
2013).	On	a	cellular	level,	it	contributes	to	adhesion	by	anchoring	the	cell	to	the	ECM.	Vice	
versa,	a5b1	is	actively	involved	in	ECM	network	formation.	Fibronectin	is	expressed	as	a	
soluble	 dimer,	 which	 assembles	 into	 fibrillary	 networks	 upon	 binding	 to	 cells,	 in	
particular	cells	expressing	a5b1	(Schwarzbauer	and	Sechler,	1999).	The	binding	of	FN	to	
a5b1	then	induces	fibrillary	assembly.	How	this	occurs	exactly,	is	still	under	investigation.	
Most	 likely,	 the	 interaction	 and	 accompanying	 force	 exertion	 induces	 conformational	
changes	in	the	FN	molecule	which	enable	the	access	of	certain	polymerization	sites.		
Integrin	 a5b1	 was	 reported	 to	 be	 overexpressed	 in	 several	 aggressive	 cancer	
types,	 such	 as	 breast,	 ovarian,	 colon	 and	 lung	 cancer,	where	 it	 contributes	 to	 tumoral	
neoangiogenesis	(Schaffner	et	al.,	2013).	As	its	overexpression	strongly	correlates	with	
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seven	 integrin-specific	 drugs	 entered	 the	 pharmaceutical	 market,	 none	 of	 which	 are	
targeting	a5b1,	whereas	the	rest	of	the	480	registered	drugs	did	not	make	it	past	clinical	
phase	trials	(Raab-Westphal	et	al.,	2017).	There	are	several	explanations	for	this	lack	of	
suitable	 integrin-targeting	 drugs.	 The	main	 reason	 probably	 lies	 in	 the	 complexity	 of	
integrin	biology.	We	 still	 do	not	understand	how	 integrins	 are	distributed	 throughout	
















structure.	 Moreover,	 several	 hydrophobic	 residues	 surrounding	 these	 residues	
contribute	to	the	synergy	site	interaction.	However,	we	did	not	observe	any	interaction	






that	 alters	 their	 orientation	 slightly	 towards	 each	 other	 and	 thus	may	 lead	 to	 further	
engagement	between	R1374	and	integrin	a5.	
Importantly,	we	unveiled	novel	FN	residues	next	to	RGD	and	synergy	site,	engaging	
in	 interaction	 with	 integrin,	 in	 particular,	 residues	 surrounding	 ADMIDAS	 in	 the	 b1	
subunit.	 The	 importance	 of	 ADMIDAS	 for	 the	 activation	 and	 headpiece	 opening	 of	
integrins	has	been	underlined	by	many	studies	over	the	recent	years,	which	show	that	
ADMIDAS	 mutations	 abrogate	 conformational	 changes	 of	 integrins	 (Zhang	 and	 Chen,	
2012).	 Along	 the	 same	 line,	 it	 has	 been	 shown	 recently	 that	 integrin	 avb8,	 the	 only	











with	 its	 physiological	 N-glycosylations.	 So	 far,	 the	 role	 of	 N-glycosylation	 for	 integrin	
a5b1	 has	 been	 studied	 extensively;	 however,	 mostly	 by	 using	 recombinant	 sample	
preparations	 (Isaji	 et	 al.,	 2009;	 Isaji	 et	 al.,	 2006).	 It	 has	 been	 shown	 that	 upon	 de-
glycosylation	 or	mutations	 of	N-glycosylation	 sites,	 integrin	a5b1	 function	 is	 severely	
impaired	since	heterodimer	formation	and	ligand	binding	are	reduced	(Guo	et	al.,	2002;	
Isaji	et	al.,	2009;	Isaji	et	al.,	2006;	Zheng	et	al.,	1994).	Our	study,	for	the	first	time,	revealed	










Integrins	 are	 thought	 to	 exist	 in	 an	 equilibrium	of	 conformational	 states,	 i.e.	 to	
continuously	 fluctuate	 between	 bent	 and	 extended-open	 states	 (Luo	 et	 al.,	 2007).	
Whenever	another	factor,	such	as	ligand	or	intracellular	protein,	is	added	to	or	removed	
from	the	system,	 the	dynamic	equilibrium	might	be	shifted	 further	to	one	side.	 In	 that	
way,	by	using	negative-stain	EM	analysis,	we	were	able	to	observe	that	all	integrin	a5b1	
conformations	 are	 present	 in	 all	 conditions.	 However,	 the	 percentage	 of	 integrins	 in	




states	varies	 strongly	between	different	 integrin	 isoforms	 (Miyazaki	et	al.,	2018).	This	
suggests	that	all	integrins	have	adapted	and	fine-tuned	their	activation	mechanism	and	
equilibrium	depending	on	their	cellular	function.	Therefore,	integrins	that	contain	b2	and	
b3	 subunits,	 which	 are	 mainly	 expressed	 on	 circulating	 cells	 (such	 as	 platelets	 and	
leucocytes),	seem	to	mainly	adopt	the	bent	conformation	when	no	activating	factors	are	
present.	 In	 the	case	of	a5b1,	however,	a	 stable	portion	of	extended	 integrins	was	also	


















In	 regard	 to	 these	 observations,	 it	 has	 often	 been	 discussed	 how	 inside-out	
activation	of	integrins	by	intracellular	factors,	such	as	talin	and	kindlin,	is	achieved.	It	has	
been	 hypothesized	 that	 activation	 of	 integrin	 by	 talin	 might	 be	 mainly	 crucial	 for	
hematopoietic	cells	but	not	for	cells	within	whole	tissues	(Klapholz	and	Brown,	2017).	



































Despite	 these	 limitations,	 our	 study	 provides	 novel	 insights	 into	 integrin	a5b1	
function	and	reveals	an	extensive	regulatory	mechanism	comprised	by	several	modules	
on	 the	 FN-integrin	 interface,	 N-glycans	 as	well	 as	 by	 a	 semi-bent	 arrangement	 of	 the	
resting	integrin	a5b1.	Getting	a	full	overview	on	how	integrins	work	is	relevant,	as	they	
are	 interesting	 therapeutic	 targets	 for	 diseases	 such	 as	 cancer.	 The	 findings	 and	







derived	 from	 these	 studies	 has	 been	 thought	 to	 apply	 to	most	 isoforms.	 Our	 findings	
highlight	that	different	integrin	isoforms	might	employ	different	activation	mechanisms	
and	need	additional	regulatory	components	present	on	both	their	ligands	and	on	integrins	
themselves.	 Earlier	 studies	 that	 suggested	 that	 integrins	 function	 in	 different	 modes	
might	have	been	neglected	and	explained	by	experimental	errors	(Arnaout	et	al.,	2005;	
Luo	 et	 al.,	 2007;	 Luo	 and	 Springer,	 2006).	 However,	 recent	 studies	 regarding	 avb8	
(Campbell	et	al.,	2020;	Cormier	et	al.,	2018)	as	well	as	our	study	of	a5b1	presented	in	this	
work	give	a	clear	indication	that	integrins	indeed	might	not	all	be	sharing	the	exact	same	












Furthermore,	 although	we	 used	 full-length	 integrin	 for	 our	 study,	 our	 cryo-EM	
analysis	only	visualized	the	ectodomains	of	a5b1	in	molecular	detail.	It	will	be	of	great	
interest	 to	 see	 the	 activation	 mechanism	 of	 full-length	 integrin	 in	 context	 of	 their	
physiological	membrane.	For	many	membrane	proteins,	it	has	been	hypothesized	that	the	
membrane	 surrounding	 is	 crucial	 for	proper	 functioning.	For	 this,	 approaches	 to	keep	
membrane	proteins	soluble,	such	as	the	nanodisc	system,	saposin-lipoprotein	(Salipro)	
or	styrene	maleic-acid	lipid	particles	(SMALP),	could	be	utilized	and	optimized	since	they	












ligand	FN	or	complex	FN	fibers,	 insights	 in	 integrin	activation,	and	possibly	clustering,	
could	be	gained	as	well.	
In	 addition,	 exploring	 the	 role	 of	 mechanical	 forces	 on	 both	 integrin-ligand	
interactions	and	structural	conformations	is	of	particular	interest.	The	effect	of	force	on	
integrin-ligand	bonds	has	been	studied	using	a	variety	of	biophysical	methods,	such	as	





engaged	 in	 the	 interaction	 in	 our	 structure.	 To	obtain	more	 information,	 the	 integrin-
ligand	interaction	would	have	to	be	subjected	to	force	on	the	cryo-EM	grid,	which	might	




breakthroughs	 allow	 for	 the	 visualization	 of	 proteins	 within	 the	 cell	 (Beck	 and	
Baumeister,	2016).	Via	focused	ion	beam	(FIB)	milling,	thin	slices	of	vitrified	cell	samples	
can	be	generated	that	enable	studying	protein	complexes	in	situ.	The	resolutions	do	not	







of	 theoretical	 interest	 but	 could	benefit	 clinical	 research	 and	 the	development	 of	 new	
therapeutic	 approaches.	By	discovering	more	 specific	molecular	 targets	on	 integrin	as	





of	 integrins	 in	 the	 last	 decades,	 many	 critical	 open	 questions	 remain,	 which	 can	 be	
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